Dermatology Associates of San Antonio v. Oliver Street Dermatology Management LLC

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

DERMATOLOGY ASSOCIATES OF )
SAN ANTONIO, DERMSA )
MANAGEMENT, INC., and )
WILLIAM T. PARSONS, M.D., )
)
Plaintiffs, )
)
v. ) C.A. No. 2017-0665-KSJM
)
OLIVER STREET DERMATOLOGY )
MANAGEMENT LLC, )
)
Defendant. )

MEMORANDUM OPINION
Date Submitted: May 5, 2020
Date Decided: August 10, 2020

S. Mark Hurd, Lauren Neal Bennett, MORRIS, NICHOLS, ARSHT, & TUNNELL
LLP, Wilmington, Delaware; James G. Ruiz, Rebecca Bergeron, WINSTEAD PC,
Austin, Texas; Counsel for Plaintiffs Dermatology Associates of San Antonio,
DermSA Management, Inc., and William T. Parsons, M.D.
Rudolf Koch, Robert L. Burns, Daniel E. Kaprow, RICHARDS, LAYTON, &
FINGER, P.A. Wilmington, Delaware; William Trach, David Rowe, LATHAM &
WATKINS LLP, Boston, Massachusetts; Counsel for Defendant Oliver Street
Dermatology Management LLC.

McCORMICK, V.C.
 This post-trial decision resolves the claim that the defendant wrongfully

terminated an agreement to acquire the plaintiffs’ Texas-based dermatology practice.

The plaintiffs contend that the defendant failed to provide notice of termination by

the contractual deadline and that the defendant lacked a proper basis for termination.

This decision finds that the notice of termination was timely. The termination

provision required the defendant to give notice of termination prior to or at closing.

The parties neither participated in a closing nor agreed upon a date for closing, so

the deadline never passed.

This decision also finds that the defendant had a proper basis for termination.

The termination provision granted the defendant the right to terminate if the

plaintiffs failed to satisfy certain closing conditions or if it became impossible to

satisfy those conditions at closing. The defendant cited two closing conditions as

grounds for termination: the plaintiffs’ obligation to obtain third-party consents

from the company’s landlords, and the plaintiffs’ obligation to deliver a bring-down

certificate stating that the representations and warranties were true and correct in all

material respects. Because closing never occurred, the deadline for satisfying the

closing conditions never expired. Thus, the plaintiffs’ claim hinges on whether it

was impossible to satisfy the two closing conditions.

This decision finds that it was possible for the plaintiffs to supply the landlord

consents, but it was impossible for the plaintiffs to satisfy the bring-down condition.
After signing, two of the plaintiffs’ physicians responsible for over 10% of the

company’s revenue stated their intent to resign. The anticipated loss of revenue

generated by these physicians would have prevented the seller from certifying that

its related representations and warranties were true in all material respects at the time

of closing. Judgment is therefore entered in favor of the defendant.

I. FACTUAL BACKGROUND
Trial took place over two days. As reflected in the Schedule of Evidence

submitted by the parties,1 the record comprises 342 trial exhibits, live testimony

from four fact and two expert witnesses, deposition testimony from nine fact and

two expert witnesses, and twenty stipulations of fact. 2 These are the facts as the

Court finds them after trial.

A. DermSA and Oliver Street
Plaintiff William T. Parsons, M.D. founded and owned Plaintiffs

Dermatology Associates of San Antonio (“Associates”) and DermSA Management,

Inc. (“Management,” and with Associates, “DermSA”). 3 DermSA operated a

dermatology and cosmetic medicine practice at three locations in the San Antonio

1
See C.A. No. 2017-0665-KSJM, Docket (“Dkt.”) 167, Joint Schedule of Evid. Ex. A.
2
The Factual Background cites to: Docket entries by docket number; trial exhibits by “JX”
number; the trial transcript (“Trial Tr.”), see Dkts. 150, 151; transcripts of the depositions
(“Dep. Tr.”) of Joseph Binder, TJ Rose, Brian Schroeder, and Geoffrey Wayne, see Dkts.
141, 146; and facts stipulated in the parties’ Amended Joint Pre-trial Stipulation and Order
(“PTO”), see Dkt. 147.
3
PTO ¶ 5.

2
area. 4 Parsons was the nominal head of Associates, 5 which employed the DermSA

physicians.6 Non-party Robert Schubert, a Certified Public Accountant, was

Parsons’s “nuts and bolts” guy. 7 Schubert ran Management, 8 which provided

administrative business support services to Associates. 9

Defendant Oliver Street Dermatology Management LLC (“Oliver Street”) is

a dermatology practice management organization.10 Oliver Street is what some

might refer to as a “roll-up” company, or a company that is built through the

acquisition of businesses that perform similar services.11 By 2013, Oliver Street had

acquired sixty-five dermatology practices.12 Non-party Derm Growth Partners I,

LLC (“Derm Growth”) owns 100% of Oliver Street. 13 Non-party ABRY Partners,

LLC (“ABRY”) owns a majority of the membership interests in Derm Growth. 14

4
Id. ¶¶ 7, 12.
5
See Trial Tr. at 125 (Schubert explaining that Texas law requires that physicians “be
employed by a company that is headed by a physician”).
6
Id. at 124 (Schubert).
7
Id. at 238 (Parsons).
8
Id. at 124 (Schubert).
9
Id.
10
Id. at 287–88 (Wayne).
11
Id. at 288 (Wayne).
12
Id.
13
Wayne Dep. Tr. at 15; see also Rose Dep. Tr. at 13–14.
14
Wayne Dep. Tr. at 17; see also Rose Dep. Tr. at 13–14.

3
 B. The Letter of Intent
Oliver Street first began exploring an acquisition of DermSA in 2013. Based

on the number of physicians at that time, DermSA was in the top five percent of

dermatology practices nationally and was the largest dermatology practice in Texas,

where Oliver Street had a large presence. 15 DermSA, therefore, presented a unique

acquisition opportunity for Oliver Street.

Oliver Street and DermSA discussed a potential transaction in 2013 and again

in 2014, but they did not reach an agreement. Ultimately, there was too big a gap

between DermSA’s value expectations and the price Oliver Street was willing to

pay. 16

15
JX-200 (9/18/13 email from Oliver Street CEO Geoff Wayne to his associates at Oliver
Street and others describing his three-hour visit with Parsons and Schubert and stating that
Oliver Street needs “to take a serious look at this one, it appears to be the largest practice
in the state (by docs) and would be a great platform, easy to recruit to, etc.”); see also Trial
Tr. at 318–19; id. at 237 (Parsons testifying that DermSA was a unique practice); id. at 217
(Schubert testifying that DermSA was “in a special situation” and, in his view, Oliver Street
needed them).
16
Trial Tr. at 290 (Wayne); see also JX-17 (10/21/13 email from Wayne to Parsons copying
Schubert and others attaching letter of intent to acquire DermSA for a sum certain); JX-
340 (10/21/13 letter of intent); JX-18 (10/24/13 email from Wayne to Lawrence Anderson,
a former associate of Parsons and previous owner of one of Oliver Street’s earlier
acquisitions, explaining that DermSA countered for a much higher EBITDA multiple); JX-
19 (10/30/13 email from Wayne to Candescent Partners, Oliver Street’s investor at the
time, explaining the details of the counteroffer and saying: “They like us and really want
to make something happen, but it is not going to be now. We agreed to stay in touch and
see how things transpire.”); JX-20 (10/31/13 email from Wayne to Schubert and Parsons
offering to acquire DermSA at a fixed EBITDA multiple); JX-342 (12/16/13 letter from
Wayne to Parsons setting forth revised indication of interest).

4
 DermSA renewed discussions in November 2015, when Schubert informed

Oliver Street’s CEO, Geoff Wayne, that Parsons “would entertain an offer of $22.5

million.”17 The parties engaged in discussions about appropriate EBITDA multiples

for the DermSA practice.18 In December, Schubert sent Wayne DermSA’s financial

projections for 2016, which reflected a projected EBITDA of $2.7 million. 19 Based

on review of DermSA’s year-end 2015 financial results and projected 2016

EBITDA, Oliver Street made an offer to purchase DermSA at $23 million.20

Wayne had reservations about a $23 million purchase price, which “equate[d]

to a multiple higher than the three largest practices in the country [had] recently sold

for.”21 At the same time, however, the market was changing as more buyers similar

to Oliver Street were entering the dermatology space.22 With demand for

dermatology practices up and supply limited, Oliver Street decided to put a premium

17
JX-202 (11/13/15 email from Schubert to Wayne).
18
JX-330 at 1 (11/17/15 email from Wayne to Schubert); see also Trial Tr. at 298 (Wayne
testifying to his perspective: “The EBITDA was not as good as I think what they even
thought it was, what DermSA -- or what it really was. And so it took a while, but I think
it was at least helpful in all of us orienting about what the real numbers were.”); id. at 299
(Wayne testifying that DermSA’s “historic financial performance would in no way justify
a $22 1/2 million number, because that’s not what people pay for practices like that”); id.
at 300 (Wayne testifying that a $22.5 million purchase price equated to a 20x EBITDA
multiple based on DermSA’s historic performance and a 12x EBITDA multiple based on
DermSA’s projected future performance, and that a 12x multiple was “just too high”).
19
JX-328 (12/22/15 email from Schubert to Wayne attaching financial projections).
20
JX-327 (1/15/16 email from Wells to Parsons copying Wayne and Schubert).
21
JX-205 at 1 (5/25/16 email from Wayne to Schubert and Parsons).
22
Trial Tr. at 306 (Wayne).

5
offer on the table. Oliver Street formalized this offer in a letter of intent, which the

parties executed on January 29, 2016.23

C. Due Diligence
The letter of intent granted Oliver Street a forty-five day period of exclusivity

to conduct due diligence.24 The parties executed four amendments to the letter of

intent extending the exclusivity period through June 2, 2016. 25 Through diligence,

Oliver Street discovered information that led it to conclude that DermSA was a

riskier acquisition than it previously believed.

Oliver Street’s first wave of concerns emerged in March 2016. Around

March 11, 2016, Schubert sent Wayne DermSA’s financial results for January and

February 2016, 26 and those financials revealed that DermSA’s actual revenues to

date were about 12% less than projected. 27 Wayne, Schubert, and Parsons met in

person to discuss these concerns on March 23. Wayne relayed Oliver Street’s

perspective that the financial review did not support an offer of $23 million, and he

23
JX-25 at 2 (1/29/16 letter of intent).
24
Id. at 5.
25
JX-27 (3/9/16 first amendment extending exclusivity period through to 4/4/16); JX-29
(4/8/16 second amendment extending exclusivity period through to 4/29/16); JX-30
(4/29/16 third amendment extending exclusivity period through to 5/13/16); JX-33
(5/12/16 fourth amendment extending the exclusivity period through 6/2/16).
26
JX-28 at 4 (3/11/16 email from Schubert to Wayne copying Wells).
27
Id. (3/11/16 email from Wayne to Schubert copying Wells).

6
reduced Oliver Street’s offer to $17 million. 28 In response, Parsons and Schubert

terminated negotiations.29

Wayne then made a proposal that he hoped would bring DermSA back to the

negotiating table. A few hours after the March 23 meeting, Wayne emailed Parsons

stating that Oliver Street would pay Parsons his asking price of $23 million if

DermSA agreed to four new terms, most of which were related to DermSA’s lagging

financial performance. 30 The new terms focused on adjusting physician

compensation downwards, charging physicians for the cost of their products,

examining other possible expenses that could be cut, and looking for other

acquisition targets in the San Antonio market. 31 DermSA agreed to make the

adjustments, and Schubert responded that he was “pleased to learn that things [were]

back on track and that [Oliver Street was] willing to pay the $23 million for

[DermSA].” 32

Oliver Street’s second wave of concerns emerged in May 2016. This wave

involved two issues. The first issue was DermSA’s facility leases. Oliver Street

28
Trial Tr. at 140 (Schubert).
29
Id.
30
JX-203 at 1–2 (3/23/16 email from Wayne to Schubert and Parsons copying Wells).
31
Id.
32
Id. (3/23/16 email from Schubert to Wayne).

7
viewed the leases as “non-market” 33 because each lease lasted for a term of fifteen

years and made the tenant responsible for HVAC and roof replacement. 34 The other

issue was the DermSA physicians’ employment agreements. DermSA employed

sixteen physicians, not including Parsons. Of those physicians, fourteen were the

company’s primary revenue drivers. 35 The physicians’ employment agreements

contained an anti-assignment provision that automatically terminated the

agreements upon the sale of DermSA. 36 Automatic termination of the employment

agreements “could potentially be disastrous for any prospective purchaser”37 in that

it “essentially could leave [the purchaser] without a business.”38

Oliver Street’s Chief Development Officer, Scott Wells, 39 identified the two

issues for Parsons and Schubert and proposed solutions for each. 40 As to the lease

33
Trial Tr. at 304 (Wayne); see also JX-204 (5/17/16 email from Wells to Parsons and
Schubert copying Wayne).
34
JX-204 at 1 (5/17/16 email from Wells to Parsons and Schubert copying Wayne).
35
Trial Tr. at 150–51 (Schubert explaining that DermSA employed sixteen physicians
“besides Dr. Parsons” but that one physician was planning to retire and Oliver Street did
not intend to retain another because she was a pathologist who was not profitable); id. at
320 (Wayne testifying that the physicians are “the revenue generators and the future of the
company”); see also id. at 308, 312–14 (Wayne).
36
See, e.g., JX-7 (employment agreement for Alfred J. Hockley, III); JX-10 (employment
agreement for Thushan N. DeSilva).
37
JX-204 at 1 (5/17/16 email from Wells to Parsons and Schubert copying Wayne).
38
Trial Tr. at 308 (Wayne).
39
PTO ¶ 9.
40
JX-204 at 1 (5/17/16 email from Wells to Parsons and Schubert copying Wayne).

8
agreements, Wells proposed that Parsons and Schubert allow Oliver Street to

negotiate better terms. 41 As to the employment agreements, Oliver Street proposed

that the physicians sign an amendment stating that they would continue to work for

Oliver Street post-closing. The amendment would also include a longer period for

noticing resignation, changes to the 401(k) plan, and new non-compete language that

included a “non-compete buyout” equal to one year of a physician’s compensation.42

Oliver Street’s proposal does not appear to have been controversial as to the

lease agreements, but the physician employment agreements seemed like a deal

breaker. Schubert inquired whether all of the physicians would be required to

execute an amendment to their employment agreement. 43 Wayne answered: “Yes,

we must have all physicians sign the amendment.” 44 With this message, negotiations

appeared to hit a “roadblock.”45

Wayne again made a proposal that he hoped would bring DermSA back to the

negotiating table. On June 1, 2016, the day before the extended exclusivity window

expired, Wayne sent a lengthy email to Parsons and Schubert. The email set forth a

41
Id. (Wells stating: “We are happy to approach the landlord about amending the
lease . . . .”).
42
Id.
43
JX-205 at 1 (5/26/16 email from Schubert to Wayne copying Parsons).
44
Id. (5/26/16 email from Wayne to Schubert copying Parsons (emphasis added)).
45
JX-35 at 1 (6/1/16 email from Wayne to Parsons and Schubert copying Wells).

9
“review [of] how far” the parties had come as well as Wayne’s view of “the realities

of the situation.”46 Wayne emphasized the parties’ history together and the trust they

had built. Wayne reiterated his concerns about the size of the EBITDA multiple:

“In your case, your 2015 EBITDA would only be worth $12-15mm to another buyer

(10-12x) at the very high end. The two largest practices in the country recently sold

at 14x (they each have more than 100 doctors and $30mm of EBITDA).” 47 He

further reiterated his concerns about the employment agreement amendments given

DermSA’s underperformance. 48

Wayne suggested two options for mitigating the risk of doctors not signing

the employment agreement amendments. The first was the offer on the table—work

toward a $23 million purchase price with all physicians executing amendments to

their employment agreement. 49 The second was to require a minimum number of

46
Id.
47
Id.
48
Id. (Wayne stating: “[W]e want you to understand that we are unable to move forward
at the current price without all physicians signing off on the assignment of their contracts
– doing so would not make sense for us, or any other buyer. This would leave any buyer
with an enormous amount of risk and uncertainty, which does not merry up with paying a
premium purchase price. Making this issue more critical to us is the EBITDA is below
expectations, so we are being asked to pay more for less.”).
49
Id. (Wayne describing the first option: “Work towards a sign and close at $23mm
purchase price. As such, we will require all physicians to sign the amendment allowing
for the contracts to be assigned to us so they are valid and enforceable. Again, something
anyone will require.”).

10
physicians to execute the amendment and deduct a set amount from the purchase

price for each physician who declined to do so. In Wayne’s words:

Create a structure where we require the signing of at least
12 of the 16 physicians, and for each physician that does
not sign we will deduct $1 mm from purchase price.
Essentially we are offering to take on additional risk under
this scenario, but must receive a reduction in purchase
price to account for doing so. 50

Of these options, DermSA chose the second. On June 2, 2016, DermSA’s

deal counsel, Paige Castañeda of Winstead PC, responded to Oliver Street’s deal

counsel, John Pitfield at Choate Hall & Stewart LLP, so indicating.51 She countered

Oliver Street’s proposed $1 million penalty per physician who did not sign with a

penalty of no more than $400,000 per physician who did not sign. 52

Wayne conferred internally regarding the negotiations with TJ Rose, a

principal at ABRY, 53 and concluded that as a condition to closing, at least twelve of

50
Id. at 1–2.
51
JX-36 at 2–3 (6/2/16 email from Castañeda to Pitfield).
52
Id.
53
Id. at 2 (6/2/16 email from Rose to Wayne: “From a numbers perspective, we are
significantly over-paying for this asset. And now we aren’t even sure we’ll have all of the
doctors committed to our new platform. This has the potential to turn out to be a very bad
deal for us. I would imagine that in past situations if a doctor or two left, we would feel
ok given the purchase price paid. Also, I can imagine other sellers/owners haven’t been as
difficult as this seller. I believe I fully understand the strategic value of the asset but we
seem to be moving farther and farther from what I thought were our key acquisition
criteria.”).

11
the fourteen physicians needed to sign the amendment. 54 Oliver Street rejected the

demand to lower the per-physician penalty from $1 million to $400 thousand.

Parsons later agreed to Wayne’s terms. Under the new structure, Plaintiffs agreed

to obtain amendments from twelve of the fourteen physicians at a cost of $1 million

for any physician that did not sign. 55

D. The APA
On July 1, 2016, DermSA, Parsons, Oliver Street, and Derm Growth entered

into an asset purchase agreement (the “APA”). 56 Under the APA, Oliver Street and

Derm Growth agreed to acquire the DermSA business and Parsons’s goodwill in the

business for a total price of roughly $23 million. 57 The consideration comprised

$20.7 million in cash in exchange for the business and $2.3 million in Derm Growth

equity in exchange for Parsons’s goodwill.58 The latter aspect of the consideration

was structured as a capital contribution by Parsons to Derm Growth. 59 The

transaction was on a timeline to close not later than August 12, 2016. 60

54
Id. at 2–3.
55
See JX-207 (6/10/16 email from Pitfield to Wayne and Wells).
56
JX-46, APA.
57
Id. § 1.5; id. at 118.
58
Id. § 1.5; id. at 118.
59
Id. at 118.
60
Id. § 1.6(a).

12
 Between signing on July 1, 2016, and the target closing date of August 12,

2016, Plaintiffs and Oliver Street attempted to convince the physicians to sign the

employment agreement amendments.

On July 7, Wayne and Schubert met with the DermSA physicians to begin

garnering support for the transaction.61 During the meeting, two DermSA physicians

expressed their discontent with the transaction, but Schubert remained optimistic

that they would not cause a problem. 62

On July 11, Wayne and Schubert again met with the DermSA physicians to

discuss the transaction.63 At that meeting, additional physicians voiced more

specific concerns about non-compete provisions in the employment agreement

amendments.64 According to Schubert, the physicians were concerned that any non-

compete provision in the agreement with Oliver Street would prevent the physicians

from practicing within eight miles of any Oliver Street practice, not just the three

DermSA branches. 65 Because Oliver Street managed dermatology practices across

61
JX-47 (7/7/16 email from Wayne to Schubert and Parsons thanking them for the
opportunity to meet with the physicians); Trial Tr. at 152 (Schubert); id. at 345–46
(Wayne).
62
Trial Tr. at 152 (Schubert); see also JX-47 at 1 (7/7/16 email from Schubert to Wayne:
“Dr. Parsons talked with the two ladies that I had some concerns with following the
meeting. He believes they’re fine and won’t cause a problem.”).
63
Trial Tr. at 153 (Schubert).
64
Id.
65
Id.

13
the country, such a provision would hamper the physicians’ professional mobility

nationwide and not just in San Antonio.66

After the July 11 meeting, eleven physicians organized and consulted attorney

Dana Remy, who sent Wayne a letter dated July 20, 2016.67 The letter stated that

the physicians would not execute the employment agreement amendments and that

they instead sought “new employment agreements which [would] ensure their

continued professional autonomy and productive work environment.” 68 The letter

also stated that Wayne should direct all communications regarding the physicians to

Remy. 69 Wayne forwarded the communication to Parsons and Schubert with a cover

email conveying both surprise and concern.70 Remy later emailed Castañeda a letter

listing the physicians’ demands on July 26, 2016. 71 The demands were forwarded

to Oliver Street. 72

66
Id.
67
JX-55 at 2 (7/19/16 letter from Remy to Wayne); Trial Tr. at 346 (Wayne). Remy stated
that she represented Mary Altmeyer, MD; Thushan DeSilva, MD; Chantal Barland
DeVillena, MD; Alfred Hockley, MD; Rinna Johnson, MD; Karla Munoz, MD; Mobolaji
Opeola, MD; Liliana Saap, MD; Dave Shriner, MD; Stephen Stahr, MD; and Lisa Walk,
MD. JX-55 at 2–3.
68
Id. at 2.
69
Id.
70
Id. at 1 (7/20/16 email from Wayne to Parsons and Schubert copying Wells and Pitfield).
71
JX-56 at 3 (7/26/16 letter from Remy to Castañeda).
72
Id. at 1 (7/16/16 email from Castañeda to Pitfield).

14
 By the August 12, 2016 closing deadline under the APA, only four of the

required twelve physicians had signed the employment agreement amendment. 73

The transaction did not close.

Oliver Street did not terminate the transaction under the APA. Instead, by

letter dated August 12, Wayne informed Plaintiffs that Oliver Street was “reserving

[its] right to terminate the [APA] because the closing condition set forth in

Section 1.6(c)(ii) has not been satisfied by today.” 74

E. Continued Negotiations
Undefeated, the parties kept pushing toward an agreement, volleying back and

forth various revised terms and frameworks intended to account for the risk of

physician departures.

On September 19, 2016, Wayne proposed terms that shifted from a “penalty

model” that penalized Plaintiffs for the failure of any doctors to sign the employment

agreement amendment, to an “incentive” model designed to “create a reward for

each doctor that does sign new contracts.” 75 The new terms involved a $10 million

73
JX-60 at 2 (Oliver Street’s 8/12/16 notice of intent not to close and reservation of right
to terminate the APA); Trial Tr. at 310 (Wayne).
74
JX-60 at 2; see also Trial Tr. at 309–10 (Wayne).
75
JX-65 at 3 (9/19/16 email from Wayne to Schubert copying others). In anticipation of
the fact that the physicians would not execute the amendments, on August 4, 2016, Wayne
had proposed a revised deal structure where Oliver Street would pay $11 million in cash
up-front, $6 million in cash divided amongst the employee physicians, which would be
required to be invested in Oliver Street, such that “each physician would have material
ownership from the beginning, but they must stay to receive the value, and $6 million in a
15
up-front cash payment and an $8 million tiered bonus pool for signing the remaining

eight physicians, with DermSA receiving $500,000 for the first four physicians and

$1.5 million per any additional physicians. 76 The proposal also involved holding $1

million in escrow and $4 million in a pool of “bonuses/equity” for physicians who

signed the employment agreement amendment. 77 Wayne concluded that if these

terms were not acceptable, then Oliver Street would “need to terminate the

agreement and focus [its] efforts elsewhere.” 78

At some point following the offer in September 2016, one of DermSA’s

physicians, Thushan DeSilva, resigned from DermSA. 79 DeSilva was a key revenue

producer, and Oliver Street expressed disappointment and concern upon the news of

his departure.80

three-year earnout payments to Parsons and Schubert, the final value dependent upon how
many physicians are still working at the end of three years.” JX-57 at 1 (8/4/16 email from
Wayne to Parsons and Schubert). This September 19 offer built off those terms.
76
JX-65 at 2–3 (9/19/16 email from Wayne to Schubert copying others); see also Trial Tr.
at 314–16 (Wayne).
77
JX-65 at 2–3 (9/19/16 email from Wayne to Schubert copying others).
78
Id. at 3 (9/19/16 email from Wayne to Schubert copying others). DermSA declined this
offer. See JX-66 at 2 (9/28/16 email from Castañeda: “That said, some modifications to
Geoff’s offer of September 19th will be required, and we trust you can consider the
changes.”).
79
JX-66 at 1 (10/4/16 email from Pitfield to Castañeda copying others); Trial Tr. at 316–
17 (Wayne).
80
JX-66 at 1 (10/4/16 email from Pitfield to Castañeda copying others stating: “We are
surprised and disappointed that Dr. DeSilva has chosen to leave the practice based on the
communications to date regarding the likelihood of the doctors remaining with the practice.
16
 DeSilva’s departure caused Oliver Street to send a further revised proposal on

October 4, 2016, reducing the maximum purchase price by $1 million to account for

the “EBITDA impact” of DeSilva’s departure.81 Oliver Street offered “$9 million

to be paid at closing, with an additional $400k per the first 5 doctors . . . who accept

the [employment agreement] amendment, and $1.5 million per the final 4 doctors

who accept the amendment.” 82 Oliver Street requested that it be allowed to “bring

the . . . proposal directly to the doctors.” 83

The next day, Schubert communicated his disappointment with Oliver Street’s

new position. 84 He stated that although he understood that DeSilva’s departure “may

have required a reduction in purchase price,” Oliver Street’s revisions were “a

disproportionate response to Dr. DeSilva’s leaving, and one that sets us back to

square one as far as negotiations with the physicians.”85 Schubert concluded that he

and Parsons were “willing to continue to negotiate a deal that would not require

those physicians’ signatures at closing” and that they “would accept a reasonable,

This impacts EBITDA materially and raises strong concern about what the remaining
doctors will do.”).
81
Id.
82
Id.
83
Id.
84
JX-67 at 1 (10/5/16 email from Schubert to Wayne copying others).
85
Id.

17
appropriate reduction in purchase price for Dr. DeSilva’s departure.”86 If Oliver

Street could not agree to those terms, the parties would need to “part ways.” 87

Throughout this time period, Oliver Street had pushed to communicate

directly with the physicians. 88 DermSA was initially resistant to the idea, stating in

August 2016 that a meeting was “premature.” 89 By September 2016, however,

DermSA agreed that Oliver Street should meet with the DermSA physicians directly

and without the presence of Parsons or Schubert, because “people are often reluctant

to speak openly . . . when their ‘bosses’ are present.” 90 A meeting was scheduled

for September 20, 2016,91 but the physicians declined to attend. 92 In his email

transmitting the October 4, 2016 revised proposal, Pitfield emphasized: “We believe

86
Id.
87
Id.
88
JX-65 at 4 (9/19/16 email from Schubert to Wayne copying Castañeda explaining
DermSA’s belief that “this group of doctors is hoping that you will perceive this roadblock
as indicating a greater future risk than actually exists. We are hoping that you will be able
to see through their tactics.”).
89
JX-62 at 1 (8/24/16 email from Castañeda to Pitfield); see also id. (Castañeda stating
that “DermSA feels that the best path to a successful transaction, from the buyer’s, seller’s
and physician employees’ perspective, is to be patient with the doctors and give them a few
more days to get back to us with their new response.”).
90
JX-63 at 1 (9/15/16 email from Wayne to Schubert).
91
Id.
92
See JX-65 at 4 (9/19/16 email from Schubert to Wayne copying Castañeda and
summarizing events of the prior week, including “the refusal of the group of physicians to
talk with [Wayne]”).

18
approaching the doctors through their lawyer is the only viable path at this point.

We do not otherwise know how to assess the likelihood of doctor retention.”93

By October 18, 2016, Oliver Street was “prepared to terminate the deal if [it

couldn’t] have the meeting.” 94 Wayne further warned DermSA that its options were

limited if Oliver Street walked away because at that point, any future terms would

result in a far lower purchase price determined by DermSA’s actual EBITDA, rather

than the original projections used in the first deal whose terms were papered three

months prior in July. 95 According to Wayne, this would “result in less than half” of

the valuation sought by Parsons.96

Despite Wayne’s warnings, Oliver Street offered to “forgo [sic] the meeting

if [DermSA was] willing to accept a materially lower purchase price.” 97 After some

back and forth, Wayne suggested that the parties “have a face to face meeting to go

over the proposal.”98 They met on October 27, 2016, and Wayne presented two

93
JX-66 at 1 (10/4/16 email from Pitfield to Castañeda copying others).
94
JX-68 at 2 (10/18/16 email from Wayne to Parsons and Schubert copying others). It
appears that this email may have been sent earlier than October 18 but that Dr. Parsons did
not respond until Wayne resent it and copied Castañeda and Schubert. See id. at 1 (Wayne
writing: “Paige and Bob, please kindly relay the email below to Dr. Parsons in the case
that he is not reading his emails with regularity.”).
95
Id. at 2 (10/18/16 email from Wayne to Parsons and Schubert copying others).
96
Id.
97
Id.
98
JX-69 at 1 (10/24/16 email chain between Wayne, Parsons and Castañeda).

19
proposal structures: one involving an up-front cash payment, and one involving a

delayed earn-out payment. 99

Parsons preferred to have the cash up front. The day after Wayne presented

him with a choice, Parsons proposed that he be paid a total of $17.7 million in up-

front consideration, divided between $15.7 million in cash and $2 million in stock.100

Wayne responded that Oliver Street would not go higher than $16 million on any

up-front consideration. 101

On October 31, 2016, Parsons accepted the $16 million up-front offer if it

could be divided between $12 million in cash and $4 million in stock. 102 Wayne

forwarded Parsons’s acceptance to Pitfield and stated: “we are back on.”103 The

parties worked to structure the new deal and paper its terms.

F. The Amended APA
On December 21, 2016, the parties executed an Amended Asset Purchase

Agreement (the “Amended APA”). 104 Under the Amended APA, Oliver Street and

99
See JX-70 at 1 (10/26/16 email from Wayne to ABRY stating that Wayne was meeting
with DermSA on October 27); JX-74 at 1 (10/28/16 email from Schubert to Wayne
regarding meeting that occurred on October 27).
100
JX-74 at 1–2 (10/28/16 email from Schubert to Wayne).
101
Id. at 1 (10/28/16 email from Wayne to Schubert).
102
JX-75 at 1 (10/31/16 email from Schubert to Wayne copying Castañeda).
103
Id. (10/31/16 email from Wayne to Pitfield copying others).
104
PTO ¶ 16.

20
Derm Growth agreed to acquire the DermSA practice and Parsons’s goodwill for a

total of roughly $16 million. 105 The structure of this consideration differed slightly

from the October 31 agreement in that it comprised $13 million in cash and $3

million in Derm Growth equity, the latter of which was structured as a capital

contribution by Parsons to Derm Growth. 106 The Amended APA obligated the

parties to “use commercially reasonable efforts to cause the Closing Date to be not

earlier than January 10, 2017 and not later than January 31, 2017.” 107

G. The Termination Provision and Relevant Closing Conditions
Section 7.1(c) of the Amended APA granted Oliver Street the right to

terminate, “[b]y notice given prior to or at the Closing,” for two disjunctive reasons:

[1] if any condition in Section 1.6 . . . has not been satisfied
as of the Closing Date or [2] if satisfaction of such a
condition by the Closing Date is or becomes impossible.108

Two conditions found in Section 1.6 are in dispute.

105
JX-91, Amended APA § 1.6; id. at 122.
106
Id. § 1.6; id. at 122; see also Trial Tr. at 323–24 (Wayne testifying on the difference in
purchase price, from Oliver Street’s perspective: “Well, the financial performance was
nowhere near the projections that they had provided to us, so that was certainly party of it.
Dr. DeSilva leaving and the general unrest in the physician base, . . . us being prohibited
[from speaking] with the physicians, raised lots of questions in our mind. So it was a
number of different factors.”); id. at 323:10–16 (Wayne further elaborating that “the idea
was we would take some of the . . . decreased purchase price amount, the $7 million delta,
and that would then be [Oliver Street’s] responsibility post-closing, to use some of those
dollars to provide consideration to the physician base so that they would sign on”).
107
JX-91, Amended APA § 1.6(a).
108
Id. § 7.1(c) (emphasis added).

21
 1. Bring-down Certification of No Material Changes in the
Business
The first disputed closing condition, found in Section 1.6(i), required that

Parsons, DermSA, and Management deliver “[a]t the Closing” a “Bring-down

Certificate” certifying that the “representations and warranties in [the Amended

APA] shall be true and correct in all material respects as of the Closing Date.”109

This decision refers to Section 1.6(i) as the “Bring-down Provision.” It states in full:

All of [Parsons’s], [Management’s] and DermSA’s
representations and warranties in this Agreement shall be
true and correct in all material respects as of the Closing
Date with the same effect as though made at and as of such
date, except (i) those representations and warranties that
address matters only as of a specified date, which shall be
true and correct in all material respects as of that specified
date; and (ii) those representations and warranties set forth
in Section 3.5 (Capitalization) and those qualified as to
materiality, Material Adverse Effect or a similar such
term, which shall be true and correct in all respects as of
the Closing Date. 110

Wayne testified that the purpose of this provision was to provide “further

confirmation that what [the parties] had agreed to, the key points of a business, are

the same as what [Oliver Street] thought they were when we signed the agreement

109
Id. § 1.6(i)(1).
110
Id.

22
back in December.” 111 Castañeda testified on cross examination of her belief that

this is generally the purpose of bring-down provisions. 112

All of Plaintiffs’ representations and warranties are found in Article 3 of the

Amended APA. In relevant part, Plaintiffs represented and warranted that no

employees intended to terminate their employment with or service to Plaintiffs.

Article 3, Section 3.16(c) provides as follows:

Schedule 3.16(c) sets forth a complete list of all
employees of, and consultants and contractors that provide
services to, the Business (collectively, the “Business
Employees”) . . . . To the knowledge of [Plaintiffs], no
Business Employee intends to terminate his or her
employment with or service to [Plaintiffs].113

The language of the preamble to Article 3 states that the representations and

warranties were “true and correct as of the date of [the Amended APA].” 114

2. Landlord Consents
The second disputed closing condition, found in Section 1.6(b)(i), required

that “[a]t the Closing, [DermSA] shall deliver or cause to be delivered . . . the

Consent to Assignment of Lease and Estoppel Certificates” from the Landlords “in

the form attached” to the Amended APA (the “Landlord Consents”). 115

111
Trial Tr. at 341 (Wayne).
112
Id. at 52–53 (Castañeda).
113
JX-91, Amended APA § 3.16(c) (emphasis added).
114
Id. art. III, pmbl. (emphasis added).
115
Id. § 1.6(b)(i).

23
 H. Events Prior to Termination
As the parties worked towards closing on the contemplated transaction, they

encountered new (and old) hurdles to consummation.

1. DermSA experienced changes in the business.
After the parties signed the Amended APA, two physicians noticed their intent

to resign from DermSA. On December 30, 2016, Plaintiffs received notice from

DermSA physician Liliana Saap that she would not be renewing her employment

contract.116 Plaintiffs notified Oliver Street a few days later. 117 Oliver Street

requested Schubert meet with Saap regarding her decision, and Schubert provided

Oliver Street a report of the meeting.118

On January 24, 2017, Plaintiffs received notice from DermSA physician

Mobolaji Opeola that she would not be renewing her employment contract.119

Plaintiffs notified Oliver Street the next day. 120 Opeola’s departure “raise[d]

116
PTO ¶ 18; JX-101 at 1–2 (12/30/16 email from Saap to Parsons and Schubert).
117
JX-104 (1/3/17 email from Schubert to Wayne copying Parsons).
118
JX-107 (1/7/17 email from Schubert to Wayne copying Parsons and Castañeda).
119
PTO ¶ 19; JX-115 (1/24/17 email from Opeola to Parsons and Schubert).
120
JX-121 at 1 (1/25/17 email from Schubert to Wayne copying others).

24
eyebrows”121 at Oliver Street because it placed “a lot of revenue at risk.”122 Schubert

met with Opeola regarding her decision and provided a report to Oliver Street.123

2. Oliver Street started looking for an excuse to terminate the
deal.
The resignation of the two physicians gave Oliver Street cold feet about the

deal. On January 27, Wayne sought to better understand from Schubert the financial

impact of the two departures.124 He requested information concerning the

collections of the departing doctors in 2016 and how many support staff positions

121
JX-138 at 2 (1/27/17 email from Wayne to ABRY team copying Oliver Street CFO,
David Hinton).
122
JX-224 at 3 (1/28/17 email from Wayne to Schubert); see Trial Tr. at 242 (Parsons) (“Q.
And what was Oliver Street’s response to receiving notice that Dr. Saap and Dr. Opeola
gave notice that they were not going to renew their employment agreement? A. They
wanted to know the financial impact. They were concerned. They wanted to know the
financial impact.”); id. at 383 (Wayne on cross examination: “Q. So every doctor that
leaves decreases the value of the company? Correct? A. Yes.”); see also id. at 334 (Wayne
on direct examination: “Well, you know, with two doctors leaving, giving notice, that’s
going to have a material financial impact to the business. . . . Despite what could have
been done to sort of plug the gaps, it wouldn’t have worked.”).
123
JX-125 at 1 (1/26/17 email from Schubert to Wayne copying others); see also See JX-
138 at 2 (1/27/17 email from Wayne to Rose and others stating: “My plan for now is to
wait and see how the [sic] assess the impact and see where we stand with the lease
assignments, and make a call mid next week.”); Trial Tr. at 162 (Schubert).
124
After Opeola’s resignation, Oliver Street requested a list of the non-renewal notice
deadlines for the other DermSA physicians, JX-118 at 1 (1/25/17 email from Wayne to
Schubert copying others), and Schubert provided them, JX-125 at 2 (1/26/17 email from
Schubert to Wayne and others attaching schedules); see also Trial Tr. at 373–75 (Wayne
testifying on cross examination: “[W]e wanted to understand their perspective on what the
impact to the organization would be. How would they be able to mitigate the loss of
[Opeola’s] production?”).

25
would be eliminated as a result of their departure. 125 Schubert responded that Saap’s

collections were $1,043,108 in 2016, despite not working for nine weeks due to a

broken hand. 126 Opeola’s collections were $1,351,095 in 2016. 127 Schubert could

not quantify the corresponding reduction in support staff positions but claimed that

the “lost revenue would be offset by other expenses besides salaries.” 128 Schubert

later added that he was “working on the financials” and hoped to have them

completed by January 30. 129

At trial it was established that for the year ending December 31, 2016, the

DermSA business booked $21,923,097 in revenue. 130 Thus, Saap’s 2016 collections

accounted for approximately 5% of DermSA’s total revenue, and Opeola’s

collections accounted for approximately 6%. Together, these two doctors thus

accounted for approximately 11% of DermSA’s total revenue in 2016. Plaintiffs’

own expert testified that the projected loss of revenue caused by the departures of

Saap and Opeola was “not minimal.” 131

125
JX-224 at 3–4 (1/27/17 email from Wayne to Parsons and Schubert).
126
Id. at 3 (1/27/17 email from Schubert to Wayne).
127
Id.
128
Id. at 4.
129
Id. at 2.
130
JX-103 (DermSA Consolidated Statement of Revenue, Expenses and Retained Earnings
For the Year Ended December 31, 2016).
131
Trial Tr. at 496 (Solomon); see also id. (Solomon agreeing that the impact of Saap’s
and Opeola’s departures would be “substantial” and crediting Wayne’s testimony in
26
 After learning of the financial impact of the physicians’ resignations, Oliver

Street determined that it needed a “path out” of the Amended APA to position itself

for renegotiations. Wayne emailed the ABRY team on January 27 with the

following options:

The purchase agreement we signed essentially gives us
two paths to get out of the deal – 1) material change in the
business or 2) lease assignments not received by 1/31. I
could and may have to argue that two doctors leaving is
material for the obvious reasons, although that could get
messy. If we want to renegotiate or walk, the best scenario
is for us not to get the lease assignments.132

Of the two options outlined by Wayne, the first was “messy” because it could

threaten Oliver Street’s financing for the deal, and Oliver Street wanted to “get the

transaction back on track” after renegotiating its terms. 133 Oliver Street had secured

financing for the transaction and had a “responsibility to [its] lenders . . . to make

sure that they have all of the information they needed to lend the money and . . .

concluding that “the revenue was going to be impacted significantly”); id. at 497 (Solomon
testifying: “Well, ‘material’ could have different meanings in different contexts. I’m
talking about the economics. And I think that a couple million dollars of revenue is
material to this business from the standpoint of value. Particularly if you’re looking at it
in the short-term, you know, the value going out just a few years. If you’re looking at it
over the course of 20, 30 years, it may not have much of an impact.”).
132
JX-128 (1/27/17 email from Wayne to ABRY team copying Hinton)
133
Trial Tr. at 368–69 (Wayne); see also JX-242 (1/29/17 internal ABRY email chain
regarding availability of financing if transaction did not close on February 1).

27
underwrite.” 134 Information regarding the physician departures could dampen the

lenders’ willingness to underwrite the financing for the deal.

Terminating on the basis of the failure to obtain Landlord Consents would

“simplify things” in Wayne’s view. 135 After vetting possibilities, 136 one ABRY

representative suggested on January 28 that “[o]ne option would be to have the

deadline pass for receiving the leases to gain more leverage to force a conversation

with the doctors.”137 This became Oliver Street’s back-up plan in the event Oliver

Street was unsuccessful in renegotiating the deal terms.

3. Plaintiffs were on track to deliver the Landlord Consents at
the Closing.
The problem with Oliver Street’s back-up plan to use the failure to obtain

Landlord Consents as a basis for termination was that Plaintiffs were on track to

timely obtain the Landlord Consents.

134
Trial Tr. at 368 (Wayne).
135
Id. at 409–10 (Wayne).
136
An ABRY representative asked whether Oliver Street was “allowed to speak with the
other MDs at DermSA.” JX-138 at 2 (1/27/17 email from Christopher Ritchie of ABRY
to Wayne). Wayne responded that Parsons and Schubert “repeatedly said absolutely no to
us visiting with the doctors since the legal letter came last summer. We all agree
completely with you that it would be great to talk to them. Just can’t force it to happen in
this situation. But will push.” Id. (1/27/17 email from Wayne to Ritchie).
137
Id. at 1 (1/28/17 email from Rose to Wayne and others); see also JX-139 at 1 (1/28/17
draft email of Hinton contemplating: “How long do we wait on the lease documents in
order to use that as a reason for not closing?”).

28
 DermSA required Landlord Consents from two landlords: Inland Private

Capital (“Inland”) and General Growth Properties (“GGP”). 138 Inland leased

DermSA two offices and GGP leased DermSA the third.

Both landlords reviewed Oliver Street’s financials as part of the approval

process. Wells and Oliver Street’s director of corporate development, Brent Ohlsen,

ran point for Oliver Street in providing the landlords with information.

From November 2016 through mid-January 2017, Inland communicated

directly with Oliver Street. Inland first requested financial information from Oliver

Street, which Wells provided on November 16.139 Inland forwarded the documents

to its financial consultant. 140 Inland later requested additional information, which

Ohlsen provided on December 6. 141 Ohlsen diligently followed-up a week later to

see if Inland required more information. 142 Inland’s consultant then requested

additional items on December 28,143 which Ohlsen provided the same day. 144

138
JX-91, Amended APA at 84.
139
JX-81 at 3 (11/16/16 email from Wells to Inland).
140
Id. at 2 (11/16/16 email from Inland to Wells and Schubert copying others).
141
JX-83 at 1–2 (12/6/16 email from Ohlsen to Inland copying others).
142
JX-86 at 1 (12/14/16 email from Ohlsen to Inland copying others).
143
JX-99 at 1 (12/28/16 email from Ohlsen to Inland’s consultant copying others).
144
Id. at 1–2 (12/28/16 email from Ohlsen to Inland’s consultant copying others). Oliver
Street’s Chief Financial Officer David Hinton, PTO ¶ 9, confirmed that he had personally
taken care of the outstanding issue, and he added: “[H]opefully we are done,” JX-100 at 1
(12/29/16 email from Hinton to Ohlsen copying Wells).

29
 After additional exchanges between Inland and Oliver Street in January

2017, 145 Inland sent the parties its “proposed Consent to Assignment of Lease”146 on

January 25. The consent did not match the form of consent attached to the Amended

APA, 147 but Oliver Street’s counsel approved the revised form via email, stating:

“I’m fine with this.”148

After Oliver Street approved the form of consent, Castañeda emailed Inland

on January 26 to confirm that Inland would release DermSA from its obligations

under the lease after it was assigned to Oliver Street.149 Inland and Castañeda

worked through a few additional revisions concerning a release of liability for

DermSA. 150

As of January 27, 2017, the Inland Landlord Consents were in execution form,

except that Inland circulated a revised draft of its consent and noted that the landlord

signature block had been revised to reflect the correct landlord entity on

145
JX-109 at 3 (1/12/17 email from Wells to Inland copying others); id. at 2 (1/12/17 email
from Inland confirming that it had received the financial analysis from its consultant and
that “the ball [was] in Inland’s court.”).
146
JX-119 at 1 (1/25/17 email from Inland to Pitfield and others attaching Inland’s
proposed consent).
147
Compare JX-119 at 12, 15, with JX-91, Amended APA at 123–129.
148
JX-119 at 1 (1/25/17 email from Pitfield to Castañeda copying others).
149
JX-126 at 1 (1/26/17 email from Castañeda to Inland copying Wayne, Pitfield, and
others).
150
JX-131 at 1–2 (1/27/17 email chain between Castañeda and Inland, copying others).

30
February 1. 151 While Oliver Street argues in this litigation that this proves that the

Inland Landlord Consents were not finalized on time, this was a detail that could

have been easily and quickly ironed out.

GGP also started its review process in November 2016.152 Although Wells

did not respond immediately to GGP’s initial email, 153 which gave Schubert some

concern that consent would not be ready in time, 154 the record reflects that Wells

attentively followed up with GGP throughout December 2016. 155 One hiccup did

emerge when GGP requested to add one of Oliver Street’s related entities to the lease

agreement. After some back and forth, Oliver Street agreed to GGP’s request to add

151
JX-151 at 1 (2/1/17 email from Inland to Castañeda copying Wayne and others); see
JX-131 at 1 (1/27/17 email from Castañeda to Inland, Pitfield, and others: “If you and John
Pitfield can please confirm that these are final, then John or I can circulate the execution
copies early next week”); JX-132 at 1 (1/27/17 email from Inland to Castañeda, Pitfield,
and others confirming that “[t]he changes look fine” in response to Castañeda’s email in
JX-131). After agreeing to a form of consent, Inland attempted to negotiate a side
agreement with Oliver Street concerning the information Oliver Street would report. There
was one email exchange in February. See JX-157 (2/3/17 email chain between Inland,
Castañeda, and others). On February 3, Inland circulated a proposed “side letter” agreement
between Inland and Oliver Street. JX-157 at 13. Inland’s representative testified at his
deposition that the side letter did not affect Inland’s “decision to move forward” and
confirmed that Inland remained “willing and able” to sign the consent. Binder Dep. Tr. at
86–87.
152
See JX-88 at 1 (12/16/16 email from Schubert to Wayne and others stating that GGP
had reached out to Wells on 11/29/16 and that Wells failed to respond).
153
See id.
154
Id.
155
JX-89 at 2 (12/19/16 email from Wells to GGP attaching financial statements for Oliver
Street Holdings LLC and seeking clarification concerning GGP’s questions).

31
the entity to the lease as a guarantor.156 GGP referred the consent to its “lease

committee” and estimated that the assignment documents would be ready for

execution at the end of January. 157 Oliver Street requested that the process be

expedited due to the expected late-January closing. 158

GGP reported on January 16, 2017, that its committee approved the lease

assignment and that the assignment documents would be ready in five business

days. 159 On January 31, GGP circulated revised versions of GGP’s lease assignment

and instructed DermSA to mail three executed copies to GGP’s office in Illinois for

GGP’s signature.160

156
In December, GGP stated that it required financial information for the signatory to the
lease assignment, Oliver Street Management LLC, whose financial statements were rolled
up into those of Oliver Street Holdings, LLC. JX-89 at 2 (12/19/16 email from GGP to
Wells). When that proved impractical, GGP asked that Holdings appear on the lease as the
tenant or a guarantor, and Oliver Street agreed to add Holdings to the lease as a guarantor.
JX-93 at 2 (12/21/16 email from Wells to Schubert, GGP, and others).
157
JX-93 at 1–2 (12/21/16 email from GGP to Schubert and Wells, copying others).
158
JX-95 at 1–2 (12/21/16 email from Wells to Inland and Schubert, copying others).
159
JX-110 at 1 (1/16/16 email from GGP to Wells copying others); see also JX-108
(1/12/17 email chain between Wells and GGP where GGP informs Wells that it would need
to present the proposed assignment to its “lease committee,” and Wells follows up a week
later to learn that the lease committee meeting had been rescheduled for January 16); JX-
120 at 1–2 (1/25/17 email chain among Wells and GGP confirming that Wells should
receive a draft of the consent by January 26).
160
JX-147 at 1 (1/31/17 email from GGP to Castañeda copying Pitfield and others
requesting that Castañeda “1. Print three (3) copies of the PDF on legal size papers; 2. Sign
and witness (where applicable); and 3. Mail all three Tenant-executed copies to my
attention at the address below [in Chicago]”).

32
 Therefore, as of late January 2017, both landlords were ready to execute the

consents. Castañeda testified that the Landlord Consents were finalized as of the

morning of January 31, 161 and even Wayne could not have been surprised at this fact.

In an earlier internal email, he documented his expectation that both Landlord

Consents would be ready on January 30 or January 31. 162 Thus, it is possible

(indeed, it is likely) that the consents would have been executed had the parties

moved to Closing.163

4. Oliver Street decided to treat January 31 as the deadline for
satisfying the closing conditions.
One way to cause DermSA to miss the deadline for delivering the Landlord

Consents was to move the deadline forward. Convenient for Oliver Street, at the

time Oliver Street was searching for a basis to terminate the Amended APA, there

was confusion concerning the Closing Date.

161
Trial Tr. at 38 (Castañeda); JX-144 at 3 (1/31/17 email from Castañeda to Pitfield stating
that “as of this morning, the last of the three landlord consents was finalized”); see also
JX-146 at 1 (1/31/17 email from GGP to Castañeda copying Pitfield and others attaching
execution versions of GGP consents); JX-147 at 1 (same); JX-148 at 1 (same).
162
JX-139 at 2 (1/28/17 email from Wayne to Rose copying others)
163
Binder Dep. Tr. at 57 (“Q. As of January 31st, was Inland ready, willing and able to
consent to the assignment of the lease? A. Yes. . . . I don’t have the sequence of dates
from recollection, but based on this review and knowing at one point we were signed off
and ready to move forward, I would agree with that statement, yes.”); Schroeder Dep. Tr.
at 57 (“Q. So as of January 16th, 2017, the lease committee had approved the assignment?
A. That is correct.”).

33
 The Amended APA does not set a Closing Date. Rather, it contemplates that

the parties would “mutually agree” upon a Closing Date. The relevant provision

states that performance “shall take place at a closing (the ‘Closing’), effective as of

12:01 a.m. EST . . . on a date to be mutually agreed by the parties (the ‘Closing

Date’).” 164 The Amended APA further obligated the parties to “use commercially

reasonable efforts to cause the Closing Date to be not earlier than January 10, 2017

and not later than January 31, 2017.”165

As of January 19, 2017, the parties had not yet agreed upon a Closing Date,

but the circumstances made it clear that they were targeting a closing no earlier than

the end of January. 166

An end-of-month Closing Date was problematic because it risked leaving the

DermSA employees without health insurance for the succeeding month. For this

reason, on January 23, 2017, Wayne emailed Schubert to ask that the Closing Date

be set for Wednesday, February 1. 167 Wayne explained that a February 1 closing

date “would allow for a clean cut from January . . . and more importantly, give us

164
JX-91, Amended APA § 1.6(a) (emphasis added).
165
Id.
166
JX-141 at 1–2 (1/19/17 email from Castañeda noting that the parties had not yet
“determined a closing date”).
167
JX-118 at 3–4 (1/23/17 email from Wayne to Schubert and others).

34
the entire month of February to meet with your employees and get them onto our

benefit plans.” 168

DermSA was resistant to further delay. Schubert responded to Wayne’s

request stating that DermSA “would like to close as soon as possible” and asked if

they could close on January 31. 169 Schubert proposed, however, that the parties go

ahead and amend the Amended APA to give them a little “wiggle room final

deadline of Feb 3.”170

Wayne responded by suggesting that the parties make February 1 the effective

date, writing:

We will need to make effective Feb 1 at 12.01am, if we do
it Jan 31 then your employees [sic] health insurance will
cancel immediately as this apparently happens at the end
of a calendar month. Making the closing effective 2/1
gives us the entire month of Feb to go over benefit plan
options with the employees and get them signed up.171

Schubert initially assented to Wayne’s request on January 24, emailing: “2/1

at 12:01 rather than 1/31 at 11:59 is ok with [Plaintiffs].” 172 Then, eight minutes

later, he withdrew that acceptance, explaining: “I was preparing this email to you

168
Id. at 3 (1/23/17 email from Wayne to Schubert and others); see also JX-121 at 1–2
(1/25/17 email from Wayne to Schubert and others); Trial Tr. at 326 (Wayne).
169
JX-122 at 2 (1/23/17 email from Schubert to Wayne and others).
170
Id.
171
Id. at 1 (1/24/17 email from Wayne to Schubert, Pitfield, and others).
172
JX-121 at 1 (1/25/17 email from Schubert to Wayne, Parsons, and others).

35
that was sent by error rather than saving it. It has not been approved by Dr. Parsons

or edited or completed. I will complete the email after lunch and get input from

Dr. Parsons and send again.mail [sic] after lunch.”173 At trial, Schubert testified that

he ultimately resent this email, but it became clear that he was mistaken. 174 Schubert

never resent the email, and DermSA never expressed consent to a February 1

effective date.

Based on Wayne’s January 24 email, Oliver Street’s position in this litigation

is that the parties only ever intended a February 1 effective date and that the Closing

Date was always set for January 31.175

There are two problems with Oliver Street’s litigation position. The first is

that the Amended APA did not default to a January 31 Closing Date, as Oliver

Street’s position seems to require. The Amended APA required the parties to

“mutually agree” upon a Closing Date. There is no evidence that Oliver Street

agreed to Schubert’s January 24 proposal to close on January 31. In fact, it is not

entirely clear that Schubert’s email was intended to be a firm offer, given Schubert’s

173
Id. (1/25/17 email from Schubert to Wayne, Parsons, and Castañeda).
174
Trial Tr. at 163–64 (Schubert); id. at 276–86 (Wayne). The Court offered Plaintiffs the
opportunity to address this factual dispute by re-calling Schubert. Id. at 286. Plaintiffs did
not take up the offer.
175
Dkt. 160, Def.’s Post-trial Br. at 27 (“[E]ven if Plaintiffs had accepted Wayne’s
counterproposal, it was to extend only the Effective Time of the transaction—not the
Closing Date itself.”).

36
additional proposal that the parties give themselves “wiggle room” until

February 3. 176

The second problem with Oliver Street’s litigation position is that

contemporaneous communications contradict it. Internal communications reflect

that Oliver Street was working toward a Closing Date of February 1. On January 22,

Wayne emailed deal counsel and others stating that the parties were “tentatively

targeting” a closing date of February 1. 177 On January 24, Oliver Street’s lender

emailed seeking confirmation that “closing date of DermSA is now 2/1,” and an

ABRY representative responded “[t]hat’s right.” 178 On January 27, Wayne emailed

Rose that they “still have a 2/1 close date in sight.” 179

Deal counsel was also working toward a Closing Date of February 1 or later.

At trial, Castañeda testified that the parties were “hoping to close on February 1st,

176
JX-122 at 2 (1/23/17 email from Schubert to Wayne and others).
177
JX-113 at 1 (1/22/17 email exchange among Wells, Wayne, and Pitfield, with Wells
stating that they were “tentatively targeting” a closing date of February 1); see also Trial
Tr. at 398 (Wayne confirming that JX-113 implied a February 1 closing date).
178
JX-256 (1/24/17 email exchange among Oliver Street’s lender and ABRY
representatives); see also JX-240 (1/24/17 email from Hinton to Ohlsen requesting
“expected debt payoffs as of 2/1”).
179
JX-128 (1/27/17 email from Wayne to Rose and others); see also JX-223 (1/27/17 email
from Hinton to Wells, Olsen, and Wayne asking: “[S]hould we still target 2/1 or something
later [for DermSA]?”); JX-139 at 1 (1/28/17 draft email of Hinton theorizing that lease
consents would be ready, which would “then put the burden back on [Oliver Street] to
execute to allow for 2/1 closing”).

37
but . . . it could have been February 2nd or 3rd.” 180 This testimony squares with the

contemporaneous evidence.

In a January 25 email to Pitfield, Castañeda wrote: “Just a reminder about the

bonus amounts. If indeed we can close on February 1st, the [Amended] APA

requires that information to be provided within 7 days prior to closing, which is

today [January 25].” 181 Pitfield thanked her, said simply that DermSA was “pulling

this together,” and did not comment concerning the February 1 closing date.182

Again on January 27, deal counsel exchanged emails reflecting their

assumption that the deal would close on February 1. Castañeda emailed Pitfield and

others: “I understand it would be effective February 1st, but when would wires go

out? We are going to request updated payoff letters from Plains Capital, so I wanted

to know whether to ask for 1.31 or Feb 1.” 183 Pitfield responded: “Will confirm

with [Hinton] on [January 30] but plan would be for wires to go on Feb 1 when we

close.”184

180
Trial Tr. at 30 (Castañeda).
181
JX-116 at 1 (1/25/17 email from Castañeda to Pitfield copying others) (emphasis added).
182
Id. (1/25/17 email from Pitfield to Castañeda copying others).
183
JX-136 at 1 (1/27/17 email from Castañeda to Pitfield and others).
184
Id. (1/27/17 email from Pitfield to Castañeda and others) (emphasis added).

38
 On January 30, Castañeda told GGP that the parties “anticipate[d] closing

February 1st.” 185 She also wrote to Pitfield that she anticipated amending the APA

to reflect a later closing date. 186 The amendment memorializing a later date never

occurred. Oliver Street did not respond to Castañeda’s January 30 email concerning

the amendment or otherwise state that it now viewed the Closing Date as January 31.

The fact is that there was no mutual agreement to any Closing Date—

January 31 or otherwise. Rather, late in the game, Oliver Street’s principals secretly

decided to treat January 31 as the Closing Date because they knew that DermSA

would not push to secure the closing deliverables by January 31. They hoped this

would “simplify things” by supplying an excuse to terminate and a platform to

renegotiate. 187

I. The Notice of Termination
Oliver Street’s efforts to renegotiate the Amended APA on the basis of the

physicians’ departures proved unsuccessful.

On January 30, Oliver Street requested a conference call with DermSA.

Pitfield wrote that the purpose was to obtain “more information regarding how to

185
JX-142 at 1 (1/30/17 email from Castañeda to GGP copying others) (emphasis added).
186
JX-141 at 1 (1/30/17 email from Castañeda to Pitfield and others). Somewhat
confusingly, in this email, Castañeda wrote: “anticipate a Second Amendment to APA to
reflect the extension of closing drop dead date.” Id. (emphasis added). The Amended
APA, however, did not contain a “drop dead date.” At trial, Castañeda testified that she
was referring to the January 31, 2017 date. Trial Tr. at 30 (Castañeda).
187
Trial Tr. at 409–10 (Wayne).

39
handle the two departing doctors post-closing,” 188 but the real purpose of the call

was for Oliver Street to demand new terms. The call took place on the morning of

January 31. Oliver Street requested that Plaintiffs assume additional risk by making

Parsons’s equity consideration contingent on DermSA physicians signing

employment agreement amendments.189

DermSA rejected Oliver Street’s proposal. After the call, Parsons and

Schubert informed Castañeda that they were not interested in renegotiating any of

the financial terms of the deal and that Parsons would not schedule a meeting

between Oliver Street and the physicians until the transaction closed.190 To them,

the Amended APA did not require “[t]hat a minimum number of physicians come

along at closing.”191 Because Oliver Street had abandoned this term and instead

188
JX-224 at 1–2 (1/30/17 email from Pitfield to Castañeda and others).
189
Trial Tr. at 32–33 (Castañeda); see also JX-160 at 1 (2/6/17 email from Wayne to Hinton
and others explaining that DermSA “came back today and tried to negotiate off of our last
‘offer’ which was given the deterioration in the practice, Parsons needs to put 2mm of his
equity rollover at risk tied to doctors signing on with us”).
190
Trial Tr. at 34 (Castañeda).
191
JX-144 at 3 (1/31/17 email from Castañeda to Pitfield). Compare JX-46, APA
§ 1.6(c)(ii) (closing condition requiring employment agreement amendment to be executed
by twelve physicians), with JX-91, Amended APA § 1.6(c)(ii), Sch. 1.6(c)(ii) (closing
condition requiring employment agreement amendment to be executed by only five
physicians who had already signed).

40
chosen to reduce the purchase price by $7 million, Plaintiffs believed that Oliver

Street bore the risk that not all of the physicians would continue their employment.192

Castañeda relayed Schubert and Parsons’s position to Pitfield and prepared to

close on the transaction. 193 At 10:37 a.m. on January 31, her associate emailed

Oliver Street’s counsel and asked whether Oliver Street’s counsel would be

“circulating execution copies of the documents to be delivered at closing.” 194 No

one responded on behalf of Oliver Street.195

Oliver Street did not respond to Castañeda’s email clarifying the Closing

Date. By that time, Wayne had made the final decision to go to Oliver Street’s back-

up plan and terminate the Amended APA. 196 Wayne wrote that night to ABRY

representative Rose: “[DermSA] refused to accept the adjusted terms and also will

192
JX-144 at 2–3 (1/31/17 email from Castañeda to Pitfield); see also Trial Tr. at 37–38
(Castañeda testifying that “Oliver Street had requested on that conference call financial
concessions. I think they had asked Dr. Parsons to make a portion of his equity
consideration, the $3 million in shares, they had asked him to make a portion of that
contingent on physicians remaining after the closing, something like that. So . . . this email
was a reminder to John Pitfield from me that we had already made the financial
concessions. Between the original asset purchase agreement and the revised asset purchase
agreement, we had reduced the purchase price by $7 million to account with uncertainty
among the physicians . . . . So Dr. Parsons was not interested in further financial
concessions.”).
193
Trial Tr. at 33–34 (Castañeda); JX-144 at 2–3 (1/31/17 email from Castañeda to
Pitfield).
194
JX-225 (1/31/17 email from Castañeda’s associate to Pitfield’s associate asking if Oliver
Street would be “circulating execution copies of the documents to be delivered at closing”).
195
Trial Tr. at 39 (Castañeda).
196
Id. at 341–42 (Wayne).

41
not schedule a doctor meeting. Beyond crazy. We will terminate and let them know

we are serious and likely talk to them in the morning.”197

Oliver Street emailed a termination notice to Plaintiffs just after 5 a.m. the

next morning, February 1, 2017.198 At trial, witnesses for Plaintiffs testified that

they were surprised to wake up to the termination notice. Castañeda testified that

Plaintiffs and their counsel were “completely shocked.”199 Schubert suffered a

debilitating heart attack that day, which he attributes to the stress of the

termination.200

The notice of termination did not provide a basis for termination.201 The

notice stated only that Oliver Street was electing to terminate “pursuant to

Section 7.1.”202

On February 1, Wayne instructed Oliver Street’s CFO: “Any communications

with [the lender] about this needs to be [that] termination was because we reached

197
JX-145 (1/31/17 email from Wayne to Rose).
198
JX-152 (2/1/17 5:25 a.m. email from Pitfield to Parsons, Schubert, and Castañeda
copying others transmitting Oliver Street’s notice of termination).
199
Trial Tr. at 40 (Castañeda).
200
Id. at 165 (Schubert).
201
See JX-152 at 2 (Notice of Termination).
202
Id.

42
the outside date and lease assignments were not received. Let’s not mention other

issues, and we hope we can get this back on track.” 203

Oliver Street stuck to this narrative when communicating with DermSA. On

February 2, Plaintiffs communicated through Castañeda their belief that termination

was wrongful and that they were entitled to immediate performance.204 In response,

Oliver Street stated that Plaintiffs did not “satisfy contractually-required

conditions . . . including but not limited to, by failing to obtain the required landlord

consents.”205 Oliver Street further stated its position that the “Closing Date was

never extended beyond January 31, 2017” because there was no writing signed by

the parties evidencing such an amendment. 206

In reality, the failure to obtain the Landlord Consents by January 31 was

pretext, as Wayne confirmed in a February 2 email to ABRY:

Short story – [DermSA] did not have the landlord consents
in hand by end of day on Jan 31, which was a condition to
close. We used this failure to terminate yesterday
morning. We did this because of the loss of the doctor last
week and the owners [sic] subsequent unwillingness to
share some risk and schedule the doctor meeting, all of
which were new asks based on the doctor leaving (just

203
JX-149 (2/1/17 email from Wayne to Hinton).
204
JX-154 at 2 (2/2/17 letter from Plaintiffs’ litigation counsel, James Ruiz, to Wayne and
Wells).
205
JX-155 at 2 (2/3/17 letter from G. Mark Edgarton of Choate, Hall & Stewart LLP to
Ruiz and Castañeda, copying others).
206
Id.

43
 want to have more insight into how the doctor base is
thinking about things).207

J. This Litigation
At the time of termination, Oliver Street intended on continuing negotiations

with DermSA toward a potential new deal.208 From February through April of 2017,

the parties continued to push for a transaction and amicable resolution. 209 Those

efforts failed. 210

Plaintiffs commenced litigation on September 15, 2017.211 Plaintiffs initially

asserted two causes of action: Count I for breach of contract and Count II for tortious

207
JX-153 at 1 (2/2/17 email from Wayne to Rose and others at ABRY) (emphasis added);
see also id. (2/2/17 email from ABRY representative to Wayne and others expressing
continued interest in a deal: “Is there a path to buying [DermSA] if we tell [Parsons] we
are happy to do so if we are able to meet with the MDs and sign them up to cash/equity
packages?”); id. (2/2/17 email from Wayne to Rose and others at ABRY: “Certainly there
is that path, but only if the owner will agree and frankly, he is behaving erratically.
Ultimately he will have to agree to whatever we do. We would still like to find a way, but
given the background and issues we truly are the only buyer.”).
208
See JX-138 at 1 (1/28/17 email from Rose to Wayne and others positing: “One option
would be to have the deadline pass for receiving the leases to gain more leverage to force
a conversation with the doctors.”); JX-149 (2/1/17 email from Wayne to Hinton advising:
“Any communication with [lender] about this needs to be termination was because we
reached the outside date and lease assignments were not received. Let’s not mention other
issues, and we hope we can get this back on track.”).
209
See JX-158 at 2–3 (2/7/17 letter from Castañeda to Pitfield); JX-227 (2/20/17 email
from Wayne to Parsons and Schubert); JX-231 (2/28/17 email from Schubert to Wayne);
JX-167 at 1–2 (4/19/17 email from Wayne to Parsons and Schubert, copying Pitfield).
210
JX-232 (4/24/17 email from Castañeda to Pitfield and others rejecting Wayne’s final
proposal and stating that Plaintiffs would take “such actions as they deem necessary to
protect their rights and interests . . . under the [Amended APA], including, without
limitation, suit for breach of contract, specific performance and monetary damages”).
211
Dkt. 1, Pls.’ Verified Compl. (“Compl.”).

44
interference with prospective business relations.212 The parties later stipulated to

dismiss the claim for tortious interference. 213 Trial concerned Plaintiffs’ Count I for

breach of contract.

II. LEGAL ANALYSIS
There are three elements of a claim for breach of contract: “1) a contractual

obligation; 2) a breach of that obligation by the defendant; and 3) a resulting damage

to the plaintiff.” 214

In the Complaint, Plaintiffs claim that Oliver Street breached the Amended

APA “by failing to close the sale on January 31, 2017, and by delivering an

212
Id. ¶¶ 27–35.
213
Dkt. 15, Stipulation & Order of Dismissal of Count II of Pls.’ Verified Compl.
214
H-M Wexford LLC v. Encorp, Inc., 832 A.2d 129, 140 (Del. Ch. 2003); see also
Connelly v. State Farm Mut. Auto. Ins. Co., 135 A.3d 1271, 1279 n.28 (Del. 2016). Each
side denies that it bears the burden of proof. PTO at 5, 8. Neither side cites in briefing to
legal authorities for its position. Typically, a party asserting a claim for breach of
contract—here, Plaintiffs—bears the burden of proving each of the elements by a
preponderance of the evidence. Triple H Family Ltd. P’ship v. Neal, 2018 WL 3650242,
at *17 (Del. Ch. July 31, 2018), aff’d, 208 A.3d 703 (Del. 2019). Multiple decisions of this
Court, however, have held that the terminating party—here, Oliver Street—“bears the
burden of ‘proving by a preponderance of the evidence the facts supporting the exercise of
its termination rights.’” Channel Medsys. v. Boston Sci. Corp., 2019 WL 6896462, at *16
(Del. Ch. Dec. 18, 2019) (quoting Akorn, Inc. v. Fresenius Kabi AG, 2018 WL 4719347,
at *4 (Del. Ch. Oct. 1, 2018), aff’d, 198 A.3d 724 (Del. 2018)); see also Akorn, 2018 WL
4719347, at *47 & n.523 (collecting cases). In the end, as the Delaware Supreme Court
has observed, the burden allocation only plays a role where the evidence is equipoise,
which occurs in “very few cases.” Ams. Mining Corp. v. Theriault, 51 A.3d 1213, 1242
(Del. 2012). In this case, the evidence is not equipoise, and thus the burden allocation is
irrelevant.

45
ineffective Notice of Termination on February 1, 2017.” 215 In briefing, Plaintiffs

slightly reformulate their claim as one for repudiation, which is basically another

word for wrongful termination.216

Under either formulation, Plaintiffs’ claim centers on whether Oliver Street

complied with the termination requirements of Section 7.1 of the Amended APA.

Section 7.1 requires that notice of termination be timely, providing that “notice [be]

given prior to or at the Closing.”217 Section 7.1 also limits the grounds on which

Oliver Street may terminate to circumstances where “any condition in

Section 1.6 . . . has not been satisfied as of the Closing Date or if satisfaction of such

a condition by the Closing Date is or becomes impossible.”218

Plaintiffs contend that Oliver Street’s termination was not timely because

Oliver Street failed to provide notice prior to the relevant deadline, which Plaintiffs

identify as January 31. Plaintiffs further argue that there were no grounds for

215
Compl. ¶ 30.
216
Dkt. 155, Pls.’ Post-trial Opening Br. at 38 (arguing that Oliver Street’s “purported
termination and subsequent refusal to perform constitute a repudiation of the [Amended
APA]”); see HIFN, Inc. v. Intel Corp., 2007 WL 1309376, at *14 (Del. Ch. May 2, 2007)
(explaining that “repudiation of a contract is an outright refusal by a party to perform a
contract or its conditions” and that a “party acts at his peril if, insisting on what he
mistakenly believes to be his rights, he refuses to perform his duty” (internal quotation
marks and citations omitted)).
217
JX-91, Amended APA § 7.1.
218
Id. § 7.1(c) (emphasis added).

46
termination because all closing conditions were or could have been satisfied prior to

or at the Closing.

Oliver Street responds that its termination was timely and proper. Oliver

Street argues that the deadline for providing notice of termination was the “Closing,”

which never occurred. By contrast, Oliver Street contends that the deadline for

satisfying closing conditions was the Closing Date, which it says was January 31.

Oliver Street further contends that Plaintiffs failed to timely satisfy the closing

conditions. At the time of termination, Oliver Street cited as the basis for termination

Plaintiffs’ failure to supply the Landlord Consents by January 31. In litigation,

Oliver Street additionally argues that termination was appropriate because it would

have been impossible for Plaintiffs to meet certain closing conditions, including the

Bring-down Provision.

This decision first grapples with the parties’ competing positions concerning

the relevant deadlines for giving notice of termination and meeting the closing

conditions. This decision then analyzes whether the closing conditions supply a

basis for termination.

A. The Deadlines
Each side of this dispute seeks to establish a deadline contemplated by the

Amended APA. Plaintiffs seek to enforce the deadline for giving notice of

termination under Section 7.1 for the purpose of arguing that Oliver Street

47
“relinquished” its termination right by not meeting that deadline. 219 Oliver Street

seeks to firm-down the deadline for satisfying closing conditions under Section 1.6

for the purpose of arguing that Plaintiffs’ failure to timely satisfy certain conditions

constituted a basis for termination.

The irony of the parties’ positions is that the two deadlines at issue are one in

the same under the plain language of the Amended APA. Section 7.1 of the

Amended APA required Oliver Street to deliver notice of termination “prior to or at

the Closing,”220 language that forecloses a party from electing to close over a breach

and then seeking to unwind after.221 Section 1.6 requires that each of the relevant

closing conditions be satisfied “[a]t the Closing.” 222 Thus, the “Closing” is the latest

date for both providing notice of termination and satisfying the closing conditions.

219
Pls.’ Post-trial Opening Br. at 29–32; Dkt. 162, Pls.’ Post-trial Reply Br. at 3–5.
220
JX-91, Amended APA § 7.1.
221
Dkt. 168, Telephonic Post-trial Oral Arg. (“Post-trial Oral Arg. Tr.”) at 36–37. This
language aligns the contractual scheme with principles of common law. See, e.g., 14
Williston on Contracts § 43:15 (4th ed. 2020) (observing restrictions on an injured party’s
ability to unwind a transaction after closing); 2 Farnsworth on Contracts § 8.20, at 8-166
to 67 (4th ed. Supp. 2019) (same). It also wards against the impracticalities of attempting
to unscramble a transaction after it has been consummated. See, e.g., Gimbel v. Signal
Cos., 316 A.2d 599, 603 (Del. Ch. 1974) (describing “the various obstacles to such a
remedy including, tax consequences, accounting practices, business reorganizations,
management decisions concerning capital investments, dividends, etc. and a host of other
problems which as a practical matter will make rescission very difficult indeed”), aff’d,
316 A.2d 619 (Del. 1974); McMillan v. Intercargo Corp., 768 A.2d 492, 500 (Del. Ch.
2000) (observing that under Delaware law, “it is generally accepted that a completed
merger cannot, as a practical matter, be unwound”).
222
JX-91, Amended APA §§ 1.6(b), 1.6(i).

48
 The Amended APA does not set a firm date for the Closing. Rather, the

Amended APA defines “Closing” as follows:

1.6 Closing

(a) Subject to completion or waiver of the closing
conditions set forth below, the purchase and sale of the
assets and the other transactions contemplated hereby . . .
shall take place at a closing (the “Closing”), effective as of
12:01 a.m. EST (the “Effective Time”) . . . on a date to be
mutually agreed by the parties (the “Closing Date”), with
the parties to use commercially reasonable efforts to cause
the Closing Date to be not earlier than January 10, 2017
and not later than January 31, 2017.223

Under this language, the Closing is an event that occurs on a Closing Date,

which was a date that the parties were required to “mutually agree[]” upon. The

parties further agreed to use commercially reasonable efforts to cause to occur on or

between January 10, 2017 and January 31, 2017.

To “mutually agree,” parties must at a minimum achieve a meeting of the

minds. 224 “In order for there to be an agreement, the parties must have a distinct

223
Id. § 1.6(a).
224
See generally 1 Williston § 3:2 (“A binding mutual understanding or so-called “meeting
of the minds” (consensus ad idem) sufficient to establish a contract requires no formality
or express language regarding every detail of the proposed agreement; it may be implied
from the parties’ conduct and the surrounding circumstances.”). See also Eagle Force
Hldgs., LLC v. Campbell, 187 A.3d 1209, 1212 (Del. 2018) (“One of the first things first-
year law students learn in their basic contracts course is that, in general, ‘the formation of
a contract requires a bargain in which there is a manifestation of mutual assent to the
exchange and a consideration.’ In other words, there must be a ‘meeting of the minds’ that
there is a contract supported by consideration.” (internal quotation marks and citation
omitted)).

49
intention common to both and without doubt or difference.” 225 “An overt

manifestation of assent”226 is important, and “[t]he unexpressed subjective intention

of a party is therefore not relevant.”227

In this case, the Closing never occurred because the parties never mutually

agreed on a Closing Date. The record reflects that Schubert proposed a January 31

Closing Date, but that proposal was not firm in view of Schubert’s simultaneous

suggestion that the parties give themselves “wiggle room” until February 3, and

Oliver Street never overtly agreed to it in any event.228 Wayne proposed a

February 1 Closing Date and then as a compromise suggested a February 1 effective

date, but DermSA never overtly agreed to that. At one point, Schubert sent an email

that seemed to consent to Wayne’s proposal, but he took back that consent eight

minutes later. 229 Oliver Street never planned on a January 31 Closing Date. Rather,

225
Gleason v. Ney, 1981 WL 88231, at *1 (Del. Ch. Aug. 25, 1981).
226
Acierno v. Worthy Bros. Pipeline Corp., 693 A.2d 1066, 1070 (Del. 1997).
227
Id.; see also 1 Williston § 4:1 (“[I]t was long ago settled that secret, subjective intent is
immaterial, so that mutual assent is to be judged only by overt acts and words rather than
by the hidden, subjective or secret intention of the parties.”).
228
JX-122 at 1 (1/24/17 email chain between Wayne, Schubert, Pitfield, and others).
229
JX-121 at 1 (1/25/17 email chain between Schubert, Wayne, Parsons, and Castañeda);
Trial Tr. at 163–64 (Schubert); id. at 276–86 (Wayne).

50
Oliver Street, 230 along with the deal lawyers, 231 was operating under the assumption

that Closing would occur on February 1 at the earliest. Thus, the record reflects only

confusion regarding the Closing Date; there was no meeting of the minds or overt

manifestation of assent. The Closing Date was never agreed upon.

Because the Closing Date was never agreed upon, Plaintiffs argue that

relevant deadline for termination is the date by which the Closing should have

occurred under the Amended APA—“not later than January 31, 2017.” 232 A

January 31, 2017 deadline for termination would render Oliver Street’s February 1,

2017 notice of termination untimely.

In advancing this construction of the Amended APA, Plaintiffs do not offer a

contextual analysis. They do not cite to parol evidence, analogous decisional

230
See JX-113 at 1 (1/22/17 email exchange among Wells, Wayne, and Pitfield, with Wells
stating that they were “tentatively targeting” a closing date of February 1); Trial Tr. at 398
(Wayne confirming that JX-113 implied a February 1 closing date); JX-240 (1/24/17 email
from Hinton to Ohlsen requesting “expected debt payoffs as of 2/1”); JX-256 (1/24/17
email from Oliver Street’s lender confirming “closing date for DermSA is now 2/1” and
ABRY representative confirming “[t]hat’s right”); JX-223 (1/27/17 email from Hinton to
Wells, Olsen, and Wayne asking: “[S]hould we still target 2/1 or something later [for
DermSA]?”); JX-128 (1/27/17 email from Wayne to Rose and others stating that he “still
ha[d] a 2/1 close date in sight”); JX-139 at 1 (1/28/17 draft email of Hinton theorizing that
lease consents would be ready, which would “then put the burden back on [Oliver Street]
to execute to allow for 2/1 closing”).
231
JX-116 at 1 (1/25/17 email chain between Castañeda and Pitfield copying others); JX-
136 at 1 (1/27/17 email chain between Castañeda and Pitfield and others); JX-141 at 1
(1/30/17 email from Castañeda to Pitfield and others).
232
JX-91, Amended APA § 1.6(a).

51
authority, or secondary sources that support their construction.233 Rather, Plaintiffs

appeal to the plain language of the Amended APA and abstract logic.

The plain language of the Amended APA does not support imposing a default

deadline of January 31. Section 1.6(a) employs an efforts clause obligating the

parties agreed to use their “commercially reasonable efforts” to cause the Closing

Date to be not later than January 31, 2017.234 Language like “commercially

reasonable efforts” does not require the identified outcome. Rather, it requires

parties to try to achieve the identified outcome. 235 In this case, it did not require that

the Closing occur not later than January 31. Rather, it required that the parties try to

233
Plaintiffs cite to a number of cases in which a court strictly enforced a contractual
deadline. See Pls.’ Post-trial Opening Br. at 30–31 (citing In re Tel. Warehouse Inc., 124
F. App’x 724 (3d Cir. 2005); Vintage Rodeo Parent, LLC v. Rent-a-Center, Inc., 2019 WL
1223026 (Del. Ch. Mar. 14, 2019); Nat’l Data Payment Sys., Inc. v. Meridian Bank, 212
F.3d 849 (3d Cir. 2000)). Those cases are inapposite because none involved disputes over
what constituted the contractual deadline, but rather, whether to enforce the deadline. Tel.
Warehouse, 124 Fed. App’x at 728 (holding that bankruptcy court, even as court of equity,
could not “use its equitable power . . . to ignore the parties’ contractual agreements” where
the parties did not agree to extend a deadline); Vintage Rodeo, 2019 WL 1223026, at *3
(declining to avoid the “startling conclusion” that a party missed a firm deadline by one
day despite “having vigorously negotiated” the provision); Nat’l Data, 212 F.3d at 855
(noting a firm deadline was the product of “substantial negotiations” and declining to
excuse a party’s “failure to focus on this unambiguous clause in the contract”).
234
See JX-91, Amended APA § 1.6(a).
235
See generally Akorn, 2018 WL 4719347, at *86–87 (describing efforts clauses,
including clauses requiring “commercially reasonable efforts,” and explaining that such
clauses specify how hard the parties have to try to achieve a specified outcome); Lou R.
Kling, Eileen T. Nugent & Brandon A. Van Dyke, Negotiated Acquisitions of Companies,
Subsidiaries and Divisions § 13.06, at 13-44 (2020 ed.) (explaining that efforts clauses are
expressed “as an attempt to achieve a desired result”).

52
cause the Closing to occur not later than January 31. The plain language does not

support enforcing a firm obligation where the parties expressly contracted for a soft

one.

Plaintiffs’ construction also would be illogical in view of the parties’

contractual scheme. Often, parties to a transaction agreement identify a “drop-dead”

or “outside” date, after which the agreement either automatically terminates or either

party can freely terminate if certain conditions are not met. 236 The “commercially

reasonable efforts” date range does not have that effect, and the Amended APA does

not otherwise contain such provisions. 237 Where, as here, the parties fail to specify

a drop-dead date, Delaware courts will keep the contract open for a “reasonable

236
Kling, Nugent & Van Dyke, supra note 235, § 15A.02, at 15A4 (“Typical termination
rights almost invariably include an outside date upon which either party can terminate,
usually by providing written notice to the other . . . .”); see also ABA Mergers &
Acquisitions Committee, Model Asset Purchase Agreement 276–77 (2010) (supplying
sample termination provision under which a buyer can terminate “if satisfaction of any
[closing condition] by _______ or such later date as the parties may agree (the “End Date”)
becomes impossible (other than through the failure of the [b]uyer to comply with its
obligations)” and commenting that the End Date supplies a “deadline by which satisfaction
of a condition either becomes impossible or the Closing has not occurred” (emphasis
added)). The deadlines in the sample provision differ from the softer efforts clause used
by the parties in this case.
237
See Rent-a-Center, 2019 WL 1223026, at *7 (quoting termination provision allowing
either party to terminate “upon written notice to the other party . . . if the Merger shall not
have been consummated by [the End Date]”); Akorn, 2018 WL 4719347, at *190 (finding
that the Outside Date served as a deadline for a seller to cure any breaches of a failure of a
condition precedent because the termination provision allowed buyer to terminate “if the
Effective Time shall not have occurred on or prior to [the Outside Date]”).

53
period of time” to allow for performance. 238 Plaintiffs’ construction of the parties’

contractual scheme, which would require Oliver Street to terminate by the

January 31, 2017 date regardless of when Closing was to occur, could result in a

“reasonable period of time” where Oliver Street was obligated to perform but had

no right to terminate on any basis. That makes no sense and is not a result for which

a buyer would bargain.

For all of these reasons, the deadline for terminating under Section 7.1 is the

Closing. Because the parties never agreed on a date to hold Closing, there was no

deadline set for giving notice of termination under Section 7.1. Oliver Street is

therefore correct that its termination notice was timely.

Oliver Street’s success on this point has a self-defeating aspect to it. The

presumption of consistent usage provides that “absent anything indicating a contrary

intent, the same phrase should be given the same meaning when it is used in different

places in the same contract.”239 Thus, the “at the Closing” language of Section 7.1240

must be read to impose the same deadline, or lack thereof, as the “at the Closing”241

238
Kling, Nugent & Van Dyke, supra note 235, § 15A.02, at 15A-4.1 (citing Henkel Corp.
v. Innovative Brands Hldgs., 2008 WL 4131566 (Del. Ch. Aug. 26, 2008)).
239
Comerica Bank v. Glob. Payments Direct, Inc., 2014 WL 3567610, at *11 (Del. Ch.
July 21, 2014) (collecting cases); see also 11 Williston § 32:6 (“Generally, a word used by
the parties in one sense will be given the same meaning throughout the contract in the
absence of countervailing reasons.”).
240
JX-91, Amended APA § 7.1.
241
Id. §§ 1.6(b), 1.6(i).

54
language of Sections 1.6(b) and 1.6(i). That is, the deadline for giving notice of

termination under Section 7.1 is the same deadline for satisfying closing conditions

set forth in Section 1.6(b) and 1.6(i). Because the deadline for giving notice of

termination did not pass, neither did the deadline for satisfying closing conditions.

The main impact of this conclusion is that Oliver Street cannot cite the non-

occurrence of a condition “at the Closing” as a basis for termination.

Oliver Street argues for an incongruous construction of the deadlines, urging

the Court to treat the deadline for meeting closing conditions as the Closing Date,

which it says was January 31, and to treat the deadline for terminating as the Closing,

which did not occur. Oliver Street cites practical reasons for this construction. As

defense counsel explained during post-trial argument, it is not uncommon for parties

to be ironing-out last-minute details relating to closing conditions on the closing

date, and to delay aspects of the closing—the release of signature pages and the

payment of money—until those conditions are satisfied.242 If the deadlines for

giving notice of termination and satisfying closing conditions are synchronous,

Oliver Street would be between a rock and a hard place, having to choose between

(1) exercising its termination right and foregoing a transaction that the parties had

worked towards closing for months, and (2) waiving its termination right

permanently. To Oliver Street, it thus makes sense for the deadline to terminate

242
Post-trial Oral Arg. Tr. at 39.

55
based on the non-occurrence of conditions to be after the deadline for satisfying

those conditions.

There are many defects with Oliver Street’s arguments. One obvious defect

is that, as discussed above, the parties never mutually agreed upon a January 31

Closing Date. The other main defect in the proposed sequence of deadlines is that

Oliver Street did not bargain for it. Under the Amended APA, the parties agreed

that the right to terminate and the obligation to satisfy closing conditions would be

subject to the same deadline—“at the Closing.” Oliver Street bargained for the

additional right to terminate before (“prior to”) the deadline for satisfying the closing

conditions if it was impossible to timely satisfy them, as is common. 243 But Oliver

Street did not bargain for the right to terminate after the deadline for satisfying the

closing conditions. In addition, the “rock and a hard place” dilemma Oliver Street

posits is overblown. Although it is true that parties often run up against contractual

deadlines, sophisticated deal lawyers routinely solve these problems by freely

agreeing to amend or extend.

243
See Model Asset Purchase Agreement, supra note 236, at 197 (supplying sample
termination provision that buyer may terminate “[b]y notice prior to or at the Closing . . .
if any condition . . . has not been satisfied . . . or if satisfaction of such a condition by such
date is or becomes impossible” (emphasis added)); id. 198 (commenting that “the
nondefaulting party may terminate . . . before the Closing if it is clear that a condition to
that party’s obligations cannot be fulfilled by the calendar date set for the Closing”).

56
 Oliver Street alternatively seeks asymmetrical enforcement of a January 31

deadline based on the Amended APA’s non-waiver provision. That provision states

that “[n]o failure to exercise or delay in exercising any right, power or remedy

hereunder shall operate as a waiver thereof.” 244 To Oliver Street, the emphasized

language plays a key role. Oliver Street argues the non-waiver provision allowed it

to delay exercising its termination right but did not permit Plaintiffs to delay

satisfying the closing condition obligations.

Once again, the finding that January 31 was not the mutually agreed upon

Closing Date renders Oliver Street’s non-waiver argument largely beside the point.

Oliver Street’s interpretation of the non-waiver provision does not work in any

event. To treat the non-waiver provision as impliedly extending the deadline for

Oliver Street to exercise its termination right after Closing runs contrary to the

purpose of the deadline. As Oliver Street argued, the purpose of a termination

deadline is to prevent Oliver Street from unwinding the transaction after Closing.

Oliver Street’s broad interpretation of the non-waiver provision, however, would

allow it to do just that. Worse, at its logical extreme, Oliver Street’s interpretation

of the non-waiver provision would lead to absurd results, allowing Oliver Street to

“mutually agree” to close by a date certain, elect to close, and then exercise its

termination right after. This is the sort of bizarre outcome that principles of contract

244
JX-91, Amended APA § 8.3 (emphasis added).

57
interpretation require courts to avoid.245 Thus, Oliver Street’s deadline for

exercising its termination right was not impliedly extended by the non-waiver

provision.246

In the end, the Closing is the deadline both to satisfy the closing conditions

and to deliver the notice of termination. The Closing never occurred. Accordingly,

the termination notice was timely, and Oliver Street cannot rely on the failure to

satisfy closing conditions “as of the Closing Date” as a basis for termination.

B. The Closing Conditions
Because the lack of a firm deadline forecloses the first avenue for justifying

termination under Section 7.1, the analysis turns to the second avenue, addressing

“if satisfaction of such a condition by the Closing Date [was] or [became]

impossible.”247 Oliver Street cites the Landlord Consents condition and the Bring-

down Provision as independent bases for termination, arguing that it would have

been impossible to satisfy either at Closing.

245
Osborn ex rel. Osborn v. Kemp, 991 A.2d 1153, 1160 (Del. 2010).
246
The cases on which Oliver Street relies to support its interpretation of the non-waiver
provision are distinguishable because application of the non-waiver provision neither
defeated the purpose of another provision of the agreement nor led to absurd results. See
Def.’s Post-trial Answering Br. at 23 (quoting AgroFresh v. MirTech, Inc., 257 F.Supp.3d
643, 660 (D. Del. 2017), and citing Pine River Master Fund Ltd. v. Amur Fin. Co., 2017
WL 4548143, at *18 (Del. Ch. Oct. 12, 2017), aff’d, 190 A.3d 996 (Del. 2018) (TABLE)).
247
JX-91, Amended APA § 7.1.

58
 1. Landlord Consents
The record reflects that it was possible to satisfy by the Closing Date the

Landlord Consents condition. In fact, the record indicates that the landlords were

ready, willing, and able to consent by the end of January 2017.248

On January 25, 2017, Pitfield consented to the form of assignment obtained

from Inland. 249 Castaneda ironed out the remaining wrinkles with Inland in the days

that followed. 250 On January 16, 2017, GGP reported that its lease committee

approved the assignment. 251 GGP circulated final execution versions on

January 31.252

248
Binder Dep. Tr. at 57 (“Q. As of January 31st, was Inland ready, willing and able to
consent to the assignment of the lease? A. Yes. . . . I don’t have the sequence of dates
from recollection, but based on this review and knowing at one point we were signed off
and ready to move forward, I would agree with that statement, yes.”); Schroeder Dep. Tr.
at 57:2–10 (“Q. So as of January 16th, 2017, the lease committee had approved the
assignment? A. That is correct.”).
249
JX-119 at 1 (1/25/17 email from Pitfield to Castañeda copying others).
250
JX-126 at 1 (1/26/17 email from Castañeda to Inland copying Wayne, Pitfield, and
others); JX-131 at 1–2 (1/27/17 email chain between Castañeda and Inland, copying
others).
251
JX-110 at 1 (1/16/16 email from GGP to Wells copying others); see also JX-108
(1/12/17 email chain from between Wells and GGP where GGP informs Wells that it would
need to present the proposed assignment to its “lease committee,” and Wells follows up a
week later to learn that the lease committee meeting had been rescheduled for January 16);
JX-120 at 1–2 (1/25/17 email chain among Wells and GGP confirming that Wells should
receive a draft of the consent by January 26).
252
JX-147 at 1 (1/31/17 email from GGP to Castañeda copying Pitfield and others
requesting that Castañeda “1. Print three (3) copies of the PDF on legal size papers; 2. Sign
and witness (where applicable); and 3. Mail all three Tenant-executed copies to my
attention at the address below [in Chicago]”).

59
 Thus, as Castañeda declared, the Landlord Consents were likely to be

finalized by the morning of January 31. 253 Even Wayne could not have been

surprised at this development, since he never doubted that the Landlord Consents

would be ready on time. 254 Because it was possible to satisfy this condition at

Closing, its purported failure cannot serve as the basis for Oliver Street’s

termination.

2. Bring-down Provision
Before turning to an analysis of the Bring-down Provision, it is appropriate to

ask whether Oliver Street should be permitted to rely on it as a basis for termination

in view of Oliver Street’s strategic decision to avoid citing to it in February 2017.

To recap, the record reflects that Oliver Street was actually terminating due to

changes with the DermSA business, but it initially withheld that reason from

Plaintiffs and the lenders, citing the Landlord Consents condition as the only express

basis for termination.255 This duplicity begs the question of whether Oliver Street

should be permitted to augment its bases for termination in this litigation.

253
JX-144 at 3 (1/31/17 email from Castañeda to Pitfield stating that “as of this morning,
the last of the three landlord consents was finalized”); see also JX-146 at 1 (1/31/17 email
from GGP to Castañeda copying Pitfield and others attaching execution versions of GGP
consents); JX-147 at 1 (same); JX-148 at 1 (same).
254
JX-139 at 2 (1/28/17 email from Wayne to Rose copying others stating Wayne’s belief
that the consents would be ready on either January 30 or January 31).
255
See supra Section I.H.4.

60
 The short and perhaps unsatisfactory response is that Plaintiffs were not

harmed by Oliver Street’s partial contrivances. In its February 2, 2017 letter, Oliver

Street flagged that there might be other reasons for termination, stating that its basis

for termination were “not limited to” the failure to obtain the required landlord

consents.”256 This is not the sort of language that gives rise to waiver or estoppel

arguments. Nor was this a situation in which the party terminating the contract

lacked a proper basis for doing so. As will be discussed next, Oliver Street was

within its contractual rights to terminate on the basis of the Bring-down Provision.

Plaintiffs did not rely upon Oliver Street’s February 2017 communications to their

detriment, and Oliver Street identified its true reasons for termination timely in this

litigation. To Plaintiffs’ credit, they make no argument that equity should cabin

Oliver Street to the specific bases for termination disclosed in February 2017. In

this case, the lack of complete candor was a shame but largely harmless.

Turning to the merits of the issue, the record reflects that it was impossible to

deliver the Bring-down Certificate at Closing.

The Bring-down Provision required Plaintiffs to certify: “All of [Parsons’s],

[Management’s] and DermSA’s representations and warranties in this Agreement

shall be true and correct in all material respects as of the Closing Date with the same

256
JX-155 at 2.

61
effect as though made at and as of such date . . . .” 257 Oliver Street contends that,

because Saap and Opeola submitted notices of their intent to resign post-signing,

Plaintiffs could not have provided this certification as to their representation in

Section 3.16, that “to the knowledge of Seller, no Business Employee intends to

terminate his or her employment with or service to Seller.” 258

Plaintiffs concede that the representation of Section 3.16 would have been

inaccurate as of the Closing Date due to Saap’s and Opeola’s resignations.259 They

argue, however, that the representation remained “true and correct in all material

respects.” 260 They further ague that, under the Bring-down Provision, the

representation of Section 3.16 need only be true and correct as of the date of signing.

In Akorn, Vice Chancellor Laster had occasion to study the meaning of the

phrase “in all material respects” as used in a merger agreement covenant. After

carefully surveying case law and treatises on this issue, the Vice Chancellor

257
JX-91, Amended APA § 1.6(i)(1).
258
Id. § 3.16.
259
Trial Tr. at 175 (Schubert testifying: “Q. Okay. So as of January 31, 2017, the
statement, ‘To the knowledge of Seller, no Business Employee intends to terminate his or
her employment with or service to the Seller,’ that was no longer true as of January 31st,
2017; correct? A. That’s correct.”); id. at 267–68 (Parsons testifying: “Q. But that
representation was not true as of January 31, 2017. Right? A. That is true.”); id. at 58
(Castañeda testifying: “Q. And so you will agree with me that the representation and
warranty that, ‘To the knowledge of Seller, no Business Employee intends to terminate his
or her employment with or service to Seller,’ that that representation and warranty itself
was no longer true on January 31st or February 1st of 2017; correct? A. That’s right.”).
260
JX-91, Amended APA § 1.6(i)(1) (emphasis added).

62
concluded that drafters use the phrase “in all material respects” in contractual

conditions “to eliminate the possibility that an immaterial issue could enable a party

to claim breach of the failure of a condition.” 261 “Build[ing] on the standard for

materiality under disclosure law,” the Vice Chancellor articulated that the “in all

material respects” standard requires a “substantial likelihood that the . . . fact [of

breach] would have been viewed by the reasonable investor as having significantly

altered the ‘total mix’ of information.” 262 Put differently, the “in all material

respects” language “strives to limit the operation of the [closing condition] to issues

that are significant in the context of the parties’ contract, even if the breaches are not

severe enough to excuse a counterparty’s performance under a common law

analysis.”263 The standard excludes those “small, de minimis, and nitpicky issues

that should not derail an acquisition.” 264

Applying the standard set forth in Akorn, it is clear that the departures of Saap

and Opeola were material. The physicians were DermSA’s primary revenue drivers,

and the departing physicians generated 11% of the total revenue in 2016, the year

261
Akorn, 2018 WL 4719347, at *85.
262
Id. at *86.
263
Id.
264
Id. at *85; see also Channel Medsys., 2019 WL 6896462, at *17 (adopting the
“disclosure-based standard that Akorn endorses in evaluating the alleged inaccuracies of
representations” in a merger agreement).

63
prior to the transaction. This Court has found adjustments and errors of comparable

size in actual or projected revenue to be material. 265

As trial, Oliver Street established that the physicians’ departures materially

affected DermSA’s projected revenue as well. DermSA did not prepare projections

for 2017. For the purpose of establishing damages at trial, Plaintiffs introduced the

expert testimony of Saul Solomon, 266 who developed financial projections for

DermSA as part of his analysis using information provided by DermSA

management. In doing so, he reduced DermSA’s projected income to account for

265
See, e.g., In re PLX Tech. Inc. S’holders Litig., 2018 WL 5018535, at *38 (Del. Ch.
Oct. 16, 2018) (finding that projections based off a 10% cut to revenue were material in
the context of stockholder approval of a merger when those projections provided “one of
only two valuations that the directors possessed when they negotiated the price of the
deal”), aff’d, 211 A.3d 137 (Del. 2019); Prairie Capital III, L.P. v. Double E Hldg. Corp.,
132 A.3d 35, 57–58 (Del. Ch. 2015) (holding at dismissal stage that misstatement of
monthly sales revenues by 10% was sufficient to infer that disclosures regarding “financial
condition” of company were not true “in all material respects”); see also In re Rural Metro
Corp., 88 A.3d 54, 104–05 (Del. Ch. 2014) (finding that 10% departure from consensus
EBITDA was material and needed to be disclosed), aff’d sub nom. RBC Capital Mkts., LLC
v. Jervis, 129 A.3d 816 (Del. 2015); IAC Search, LLC v. Conversant LLC, 2016
WL 6995363, at *12 (Del. Ch. Nov. 30, 2016) (reasoning at dismissal stage that a
misstatement of transactions with a cumulative value of $253,000 in the context of a $90
million deal was sufficient to infer that financial statements were not true “in all material
respects”).
266
JX-191, Expert Report of Saul Solomon ¶ 5. Oliver Street introduced its own valuation
expert, James L. Canessa, to rebut Solomon’s testimony. See JX-195, Rebuttal Report of
James L. Canessa. Canessa does not address the materiality of the physician departures.

64
the departures of Saap and Opeola.267 At trial, Solomon testified that this lost

revenue was “a couple million dollars” and “substantial,” “not minimal.” 268

Oliver Street’s reaction to the news of the physicians’ departures, as reflected

in the contemporaneous evidence, further demonstrates that Oliver Street viewed the

information as “significant in the context of the parties’ contract.” 269 After Opeola’s

departure, Oliver Street requested a list of the non-renewal notice deadlines for the

other DermSA physicians.270 After Schubert provided these the following day,271

Wayne followed up the day after to better understand the financial impact of the two

departures.272 He requested information concerning the collections of the departing

267
JX-191, Expert Report of Saul Solomon ¶ 32; see also Trial Tr. at 426 (Solomon
explaining on direct that DermSA experienced a “big decline in EBITDA” in part due to
“the three doctors who had already noticed their resignations as of January 31”); id. at 492
(Solomon explaining on cross that he adjusted historical EBITDA downward “to project
what we thought was going to happen with the doctors that were leaving”).
268
Trial Tr. at 496 (Solomon); see also id. (Solomon agreeing that the impact of their
departures would be “substantial” and crediting Wayne’s testimony in concluding that “the
revenue was going to be impacted significantly”). When asked whether the lost revenue
was “material” in his view, Solomon concluded in no uncertain terms that “I think that a
couple million dollars of revenue is material to this business from the standpoint of value.”
Id. at 497 (Solomon). Although Solomon qualified this statement by noting that “material”
can have different meanings in different contexts, he later testified on cross that “two
doctors left, and that materially harms the value of [DermSA].” Id. at 497, 493.
269
Id.
270
JX-118 at 1 (1/25/17 email from Wayne to Schubert copying others).
271
JX-125 at 1 (1/26/17 email from Schubert to Wayne and others attaching schedules).
272
JX-224 at 4–5 (1/27/17 email from Wayne to Parsons and Schubert); see also Trial Tr.
at 373–75 (Wayne testifying on cross examination: “[W]e wanted to understand their
perspective on what the impact to the organization would be. How would they be able to
mitigate the loss of [Opeola’s] production?”).

65
doctors in 2016 and how many support staff positions would be eliminated as a result

of their departure. 273 At trial, Wayne explained that this information was crucial

because “two doctors leaving [would] have a material financial impact to the

business.” 274 Even Parsons admitted at trial that upon hearing of Saap’s and

Opeola’s resignations, Oliver Street expressed immediate “concern[]” and “wanted

to know the financial impact.” 275

The parties’ negotiation history corroborates that the physicians’ departure

were “significant in the context of the parties’ contract.” 276 At each turn, Oliver

Street was primarily concerned with attracting the physicians and keeping them on

board with the transaction. During Oliver Street’s original diligence in May 2016,

Oliver Street identified the problematic anti-assignment provision in the physician

contracts and required that every physician sign an amendment overriding the

273
JX-224 at 4 (1/27/17 email from Wayne to Parsons and Schubert).
274
Trial Tr. at 334 (Wayne); see also JX-35 at 1 (6/1/16 email from Wayne to Parsons and
Schubert copying Wells stating that a failure of any physician to sign the employment
agreement amendment “would leave any buyer with an enormous amount of risk and
uncertainty, which does not merry up with paying a premium purchase price”); JX-66 at 1
(10/4/16 email from Pitfield to Castañeda and others stating that DeSilva’s departure
“impacts EBITDA materially”); Trial Tr. at 383 (Wayne on cross examination: “Q. So
every doctor that leaves decreases the value of the company? A. Yes.”).
275
Trial Tr. at 242 (Parsons). Plaintiffs argue that Oliver Street waived its right to terminate
based on the materiality of physician departures by not raising the issue after Saap’s
resignation. The reality is that departures had a cumulative effect, and Oliver Street raised
its concerns with Parsons and Schubert in a timely manner once, in their view, a materiality
threshold was reached.
276
Akorn, 2018 WL 4719347, at *86.

66
provision.277 After some negotiation, Oliver Street settled on requiring only twelve

physicians to sign an amendment but still imposed a $1 million penalty for each

doctor short of fourteen. 278 Oliver Street repeatedly emphasized the importance of

meeting with the physicians directly to win them over because any lack of buy-in

“could leave Oliver Street without a business.”279 When DeSilva resigned, Oliver

Street expressed disappointment regarding the associated lost revenue and reduced

the up-front cash payment accordingly by $1 million, 10% of the up-front payment

at the time. 280 The physicians were Oliver Street’s primary concern from day one of

negotiations, and both parties knew that any departures would have consequences.281

277
JX-205 at 1 (5/26/16 email from Wayne to Schubert copying Parsons).
278
JX-207 (6/10/16 email from Pitfield to Wayne and Wells).
279
Trial Tr. at 308 (Wayne); see also JX-36 at 1 (6/2/16 email from Rose to Wayne stating
that the physicians were “99% of the asset value”).
280
JX-66 at 1 (10/4/16 email from Pitfield to Castañeda copying various people stating:
“We are surprised and disappointed that Dr. DeSilva has chosen to leave the practice based
on the communications to date regarding the likelihood of the doctors remaining with the
practice. This impacts EBITDA materially and raises strong concern about what the
remaining doctors will do.”).
281
Plaintiffs also argue that emails sent by Wayne in September 2016 and October 2016
demonstrate that Oliver Street agreed to bear the risk of any physicians departing between
signing and closing. See JX-66 (9/19/16 email from Wayne to Schubert and others
explaining the shift from a “penalty” model to an “incentive” model such that Plaintiffs’
consideration was not reduced if physicians did not “come along under the new contracts”);
JX-69 at 2–4 (10/18/16 email from Wayne to Castañeda, Schubert, and Parsons stating that
Oliver Street would forego a meeting with the doctors if Plaintiffs would accept a
“purchase price reduction [that] would account for the increased risk [Oliver Street was]
assuming”). At most, the emails reflect that Oliver Street bore the risk that some physicians
would not sign additional employment agreement amendments between signing and
closing, not that any physicians would resign altogether.

67
 Thus, the departures of Opeola and Sapp were material in this context, and the

Bring-down Certificate could not be delivered at Closing because Plaintiffs’

representation and warranty in Section 3.16 was not true “in all material respects.”

To avoid this outcome, Plaintiffs argue that under the Bring-down Provision,

the representations and warranties in Section 3.16 need only be true as of signing.

They rely on a specified-date exception to Section 3.16 that requires “those

representations and warranties that address matters only as of a specified date, . . .

shall be true and correct in all material respects as of that specified date.”282 They

point to language in the preamble of Article 3, which states that “each of the

statements contained in this Article 3 is true and correct as of the date of this

Agreement.” 283 According to Plaintiffs, all of the representations and warranties in

Article 3 fall within the specified-date exception to the Bring-down Provision as a

result of the “as of the date of this Agreement” language in the preamble. Under this

interpretation, Plaintiffs were only required to certify that “no Business Employee

intends to terminate his or her employment with or service to Seller” as of the date

of signing.

Plaintiffs’ construction of the Amended APA fails for two reasons. First, if

Plaintiffs’ reading of the Amended APA were correct, the language of

282
JX-91, Amended APA § 1.6(i)(1).
283
Id. art. III pmbl.

68
Section 1.6(i)(1) requiring certification that Plaintiffs’ representations and

warranties were true “as of the Closing Date” would be rendered a nullity, because

all of Plaintiffs’ representations and warranties are found in Article 3 and would be

subject to the specified-date exception. Delaware law rejects interpretations of

contracts that render provisions null and void. 284 Second, Plaintiffs’ reading of the

Bring-down Provision undermines the well-understood function of that condition,

which is to “protect[] each party from the other’s business changing or additional,

unforeseen risks arising prior to closing.” 285 If the Bring-down Provision need only

be true as of the signing, then it would not achieve its purpose of protecting against

business changes that arise between the signing and closing.

In sum, Plaintiffs could not possibly have satisfied the Bring-down Provision

at Closing. Oliver Street was therefore within its right to terminate the Amended

APA under Section 7.1. 286

284
Kuhn Const., Inc. v. Diamond State Port Corp., 990 A.2d 393, 396–97 (Del. 2010) (“We
will read a contract as a whole and we will give each provision and term effect, so as not
to render any part of the contract mere surplusage.”); Sonitrol Hldg. Co. v. Marceau
Investissements, 607 A.2d 1177, 1184 (Del. 1992) (“The cardinal rule of contract
construction is that, where possible, a court should give effect to all contract provisions.”);
Rent-a-Center, 2019 WL 1223026, at *13 (“[A]ll the provisions are assumed to have
meaning.”).
285
Kling, Nugent & Van Dyke, supra note 235, § 14.02[1], at 14-9; see also Trial Tr. at
52–53 (Castañeda); id. at 341 (Wayne).
286
Because the Court concludes that Oliver Street did not breach the Amended APA, it
does not reach the issue of damages. This moots Oliver Street’s pending motion to exclude
evidence related to Plaintiffs’ damages calculations, see Dkt. 121, which the Court held in
abeyance pending trial, see Dkt. 152 at 13–14.

69
III. CONCLUSION
For the foregoing reasons, judgment is entered in favor of Oliver Street.

70